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ABSTRACT

Epigenetic Regulation of Embryonic and Intestinal Stem Cells
by DNA hydroxymethylation

Rinho Kim
Dr. Klaus H. Kaestner

DNA methylation at the 5 position of cytosine is a well-characterized epigenetic
modification that is important for essential cellular processes including stem cell
proliferation and differentiation. 5-methylcytosine (5mC) can be oxidized by the Ten
Eleven Translocation (TET) family of enzymes to 5-hydroxymethylcytosine (5hmC),
which has been suggested as either an intermediate in DNA demethylation or as an
independent epigenetic modification that directly regulates gene expression. Gene
silencing and activation are important processes in embryonic stem cells (ESCs) and
intestinal stem cells (ISCs) for their self-renewal and differentiation, but our
understanding of the potential role of 5hmC and TET hydroxylases in these processes is
still limited.
Here, I generate genome-wide maps of the 5hmC mark in ISCs and their
differentiated progeny and utilize Tet1-/- mice model to investigate the role of TET1 in
the intestinal epithelium. Genes with high levels of hydroxymethylation in ISCs are
strongly enriched for developmental regulation functions. The Tet1-deficient postnatal
intestine shows significantly reduced numbers of proliferative cells and decreased Wnt
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target genes expression, which correlates with lower 5hmC levels at their promoters.
These data demonstrate that Tet1-mediated DNA hydroxymethylation is important for the
self-renewal of the intestinal epithelium.
To determine a novel role of 5hmC, we perform integrative analyses of various
epigenomic sequencing datasets, and identify a group of distal transcription factor
binding sites as putative silenced enhancers, which are lacking active histone marks and
nascent transcription, but are nevertheless highly enriched for the 5hmC modification in
ESCs. During lineage specification of ESCs, these silenced elements lose 5hmC and
acquire the H3K4me1/2 histone marks and become active. I demonstrate that these
elements function as enhancers when the 5hmC mark is removed by a reporter assays.
These data suggest that 5hmC suppresses the activity of a specific subset of enhancers in
ESCs.
In summary, DNA hydroxymethylation contributes to both transcriptional
activation and repression for epigenetic gene regulation in stem cells.
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Introduction
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1.1 Development and structure of the intestinal epithelium
	
  

The intestine is a simple tubular organ that connects the stomach to the anus, and
is essential for the absorption of nutrients and water. In mice, the gastrointestinal tract
originates from the endoderm at embryonic day (E) 7.5, and is regionalized along the
anterior-posterior axis into foregut, midgut and hindgut, guided by epithelialmesenchymal interactions at E 8.5 (Figure 1.1). The small intestine and colon are
developed from the midgut and hindgut, respectively, while the foregut gives rise to the
esophagus and stomach, as well as the gut-associated organs thyroid, ling, liver, and
pancreas (Zorn and Wells, 2009).

Figure 1.1 Development of the intestine. (Left) The major events during endoderm
organ formation between E 7.5 to 9.5. (Right) Endoderm cell lineages of the
gastrointestinal tract. Adapted from (Zorn and Wells, 2009).
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The intestinal epithelium is structured as a pseudostratified epithelium until E
13.5 (Figure 1.2). After this point, mesenchymal clusters appear around epithelial cells,
which secrete hedgehog (Hh) and platelet-derived growth factor A (Pdgfa), and drive
villus morphogenesis at E 14.5 (Figure 1.2; (Karlsson et al., 2000; Madison et al., 2005;
Walton et al., 2012)). During villus morphogenesis, the pseudostratified epithelium is
transformed into a columnar epithelium with stereotypical villi that project into the
lumen, and proliferative intervillus regions. The intervillus epithelium is reshaped to
develop crypts in the first week after birth in mice. The maturation of villus and crypt
continues until the weaning age, when mice are approximately 3-4 weeks old (Wells and
Spence, 2014). During human development, villus and crypt development occur
prenatally.

Figure 1.2 Villus and crypt formation. At E 14.5, mesenchymal clusters (orange) is
required for villus morphogenesis. As the epithelium remodels between E 14.5 to 16.5,
the fetal intestinal epithelium consist of villus (green) and proliferative intervillus
(yellow) regions. The mature adult crypt contains the intestinal stem cells (yellow) and
secretory Paneth cells (red), as well as several additional cell types, such as enterocytes
(green), goblet cells (blue) and enteroendocrine cells (purple). Adapted from (Wells and
Spence, 2014).
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The mature small intestinal epithelium is composed of a single layer of cells that
contains stem, transit-amplifying and four different lineages of differentiated cells, such
as enterocytes, goblet cells, enteroendocrine cells and Paneth cells (Figure 1.2; (Cheng
and Leblond, 1974b)). Enterocytes are absorptive cells, which have a brush border on
their apical surface and also secrete hydrolytic enzymes essential for the digestion of
food. Goblet cells secrete mucus, which lubricates and protects the intestinal wall from
liminal contents. Enteroendocrine cells are rare and secrete various hormones such as
peptides and catecholamines. Paneth cells reside at the bottom of the crypt and secrete
antibacterial proteins such as lyzosomes and defensins in the small intestine, but not the
colon.
The intestinal epithelium is the most rapidly renewing tissue in human body. This
renewal process takes only five days to complete and is fueled by intestinal stem cells
(Heath, 1996; Potten and Loeffler, 1990). Intestinal stem cells reside at the crypt base and
give rise to rapid-cycling transit-amplifying cells that differentiate into mature epithelial
cells migrating up along the crypt-villus axis, and that are shed at the top of the villi.
Only Paneth cells move downward to the bottom of the crypt and have a longer life span
of 6-8 weeks. Rapid renewal and distinctive morphology make the intestinal epithelium
an excellent model to study the mechanisms underlying cell proliferation and
differentiation in adult tissues. To maintain normal function of the intestinal epithelium,
precise regulation of cell proliferation and differentiation is essential (Crosnier et al.,
2006).
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1.2 Wnt signaling in intestinal development and homeostasis
	
  

Wnt signaling is involved in many aspects of embryonic development and adult
tissue homeostasis, and the signaling molecules are highly conserved across metazoans
(van Amerongen and Nusse, 2009). The canonical Wnt pathway relies on β-catenin as its
key effector. In the absence of a Wnt signal, cytosolic β-catenin (β-cat) is maintained at a
minimum by the 'destruction complex composed of ademomatous polyposis coli (APC),
Axin, glycogen synthase kinase 3 β (GSK3β) and Disheveled (Dvl)’ (Figure 1.3; (Logan
and Nusse, 2004)). Wnt signaling is activated by binding of secreted Wnt ligands to the
transmembrane Frizzled sreceptor and the low-density lipoprotein receptor protein (LRP)
that mediate downstream Wnt signaling (Figure 1.3; (Bhanot et al., 1996; Pinson et al.,
2000)). Binding of R-spondins (R-spo) to leucine-rich repeat-containing G-protein
coupled receptor (Lgr) 4/5/6 receptor stabilizes Frizzled to potentiate Wnt signaling
(Figure 1.3; (Carmon et al., 2012; de Lau et al., 2011)). Activation of the Wnt pathway
leads to destabilization of the destruction complex and translocation of β-catenin. Nuclear
β-catenin interacts with DNA-binding proteins termed somewhat misleadingly 'T-cell
factor/lymphoid enhancer-binding factor (TCF/LEF)' to regulate transcription of contextspecific Wnt target genes (Figure 1.3; (Clevers and van de Wetering, 1997; Logan and
Nusse, 2004)).
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Figure 1.3 Wnt signaling pathway. (Left) In the absence of Wnt ligand, the destruction
complex containing APC, Axin, GSK3β, and Dvl phosphorylates β-cat and leads its
degradation in the cytoplasm. In the nucleus, TCF/LEF is inactive and Wnt target genes
are “OFF”. (Right) Upon binding of Wnt ligand to the Frizzled and the LRP with binding
of R-spo to Lgr for enhancing signals, the destruction complex is disintegrated.
Accumulated β-cat could translocate into the nucleus and interact with TCF/LEF
transcription factor to upgegulate Wnt targe genes “ON”. Adapted from (Jansson et al.,
2015).

Wnt signaling regulates multiple aspects of embryonic intestinal development and
adult intestinal homeostasis. During embryonic development, β-catenin is known as an
essential factor for endoderm formation (Imai et al., 2000; Lickert et al., 2002) In mice,
Wnt signaling is active at E 7.5 in the posterior endoderm and transiently induces caudalrelated homeobox 2 (Cdx2), the master regulator of intestinal development (Gao et al.,
2009; Sherwood et al., 2011). Until E 14.5, the Tcf4-deficient intestine shows no
noticeable difference in the tissue organization and cell proliferation. However, at E 16.5
and afterward, a reduced number of villi and loss of proliferating cells in intervillus
6	
  	
  

regions are observed in the small intestine of the mutant mice, leading to neonatal
lethality (Korinek et al., 1998). In addition, canonical Wnt signaling is active in
intervillus regions after birth, suggesting that Wnt signaling may play an important role in
de novo crypt formation and crypt fission in mice (Kim et al., 2007).
The Wnt pathway is the master regulator of intestinal epithelial regeneration in
the adult. Active Wnt signaling in intestinal crypt is a major driving force for intestinal
stem cell renewal and proliferation of transit-amplifying (TA) cells. Tight regulation of
Wnt signaling is critical for the intestinal epithelial homeostasis (Gregorieff and Clevers,
2005). Reduced Wnt signaling results in loss of crypt regenerative capacity.
Overexpression of the Wnt antagonist Dickkopf1 in adult transgenic mice or intestinal
epithelial-specific deletion of β-catenin leads to reduced proliferation, loss of crypts and
reduced numbers of secretory cells (Ireland et al., 2004; Pinto et al., 2003). Recently,
ablation of Wnt-secreting Forkhead box L1+ (Foxl1+) intestinal mesenchymal cells or
deletion of the Wntless gene, which is required for the secretion of Wnts, in adult mice,
was shown to cause loss of intestinal stem cells and impairment of intestinal homeostasis
(Figure 1.4; (Aoki et al., 2016; Valenta et al., 2016)). In contrast, aberrant activation of
Wnt signaling leads to intestinal neoplasia. For instance, deletion of Apc in Lgr5+
intestinal stem cells results in constitutively active Wnt signaling and leads to widespread
transformation (Barker et al., 2009).
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Figure 1.4 Wnt signaling in intestinal homeostasis. (Left) Intestinal homeostasis is
maintained in normal condition. Wnts are secreated from Paneth cells and mesenchymal
cells. (Middle and Right) Wnts secretion is globally blocked by deletion of Wntless gene.
(Middle) Loss of intestinal stem and TA cells without Wnt signaling. (Right) Intestinal
stem and TA cells are survived with exogenous reconstitution of Wnt3a or Wnt2b.
Adapted from (Valenta et al., 2016).
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1.3 Intestinal stem cells and organoids
	
  

Two intestinal stem cell compartments have been reported in the literature: the '+4
cell' model and the 'crypt base columnar cell' model. +4 cells reside immediately above
the Paneth cells in the ‘+4’ position when counted from the crypt base. This was a
population characterized by slow cycling and long term retention of a label incorporated
into DNA during S-phase, and proposed to be the intestinal stem cell (Potten et al., 1974).
Many studies identify various +4 stem cell markers including Bmi1, homeodomain-only
(Hopx),

telomerase

reverse

transcriptase

(Tert)

and

Leu-rich

repeats

and

immunoglobulin-like domains 1 (Lrig1), which were confirmed by genetic lineage
tracing to contribute to all differentiated epithelial cell lineages. (Figure 1.5;
(Montgomery et al., 2011; Powell et al., 2012; Sangiorgi and Capecchi, 2008; Takeda et
al., 2011)). The situation might be even more complex, as it was suggested recently that
+4 cells marked by Hopx/Bmi1-CreER are non-overlapping with the +4 label retaining
cells (Li et al., 2016).
Crypt base columnar (CBC) cells are located at the crypt base and intermingled
with Paneth cells (Cheng and Leblond, 1974a). Recently, several markers of CBC cells
have been identified, such as Lgr5, Musashi homologue 1 (Msi1), olfactomedin 4 (Olfm4)
and Achaete–Scute homologue 2 (Ascl2). These cells were confirmed by genetic lineage
tracing and in vitro culture as actively dividing stem cells (Figure 1.5; (Barker et al.,
2007; He et al., 2007; Sato et al., 2009; van der Flier et al., 2009a; van der Flier et al.,
2009b)).
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Figure 1.5 Intestinal stem cells: +4 and CBC stem cells. Summary of intestinal stem
cell pools with their markers. +4 stem cells are located the fourth position from the crypt
bottom. They are relatively quiescent, resistant to acute damage and retain DNA labels.
CBC stem cells are intermingled with Paneth cells. They are highly proliferative and
sensitive to damage. Adapted from (Barker, 2014).

Interestingly, proliferative CBC stem cells are dispensable for intestinal epithelial
homeostasis, as quiescent +4 stem cells are activated when CBCs are ablated. Thu upon
deletion of Lgr5+ stem cells by genetic ablation or radiation, Bmi1+ stem cells actively
give rise to Lgr5+ stem cells to rapidly recover the entire intestinal epithelial cell sheet
(Tian et al., 2011; Yan et al., 2012). Conversely, Lgr5+ stem cells can also give rise to
Bmi1+ stem cells in intestinal organoids in vitro (Takeda et al., 2011).
Precursor/progenitor cells of the intestinal epithelium also show their cellular
dedifferentiation capacity (Figure 1.6). Absorptive progenitor cells expressing alkaline
phosphatase around position +6 upward and secretory progenitor cells expressing the
Notch ligand Dll1 in the +4 position can dedifferentiate into stem cells in vivo to
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regenerate entire crypt-villus units upon stem cell loss (Tetteh et al., 2016; van Es et al.,
2012b). A quiescent label-retaining cell (LRC) population around the +4 position serves
as Paneth and enteroendocrine cells precursor, and does not contribute to the stem cell
pool during homeostasis. However, a subset of this population expresses Lgr5 and +4 cell
markers and gives rise to proliferative intestinal stem cells under conditions of cytotoxic
damage (Buczacki et al., 2013).

Figure 1.6 Intestinal stem cell hierarchy. Quiescent (Bmi1+ +4 cells) and active cycling
(Lgr5+ CBC) intestinal stem cells produces absorptive progenitor, which give rise to
enterocyte, and secretory precursor cell that located around the +4 position and generates
cycling secretory progenitor cells, which produce goblet, Paneth and enteroendocrine
cells. Both precursor and progenitor cell can repopulate Lgr5+ CBC cycling stem cell
after loss of Lgr5+ CBC cell by injury. Adapted from (Visvader and Clevers, 2016).
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Intestinal stem cells and crypts from the adult intestine grow into threedimensional intestinal organoids in culture with Matrigel matrix (Jung et al., 2011; Sato
et al., 2009). These organoids consist of crypt and villus domains, and contain stem cell
and all the differentiated cell types, which mimic the in vivo structure of the intestinal
epithelium (Figure 1.7). Intestinal organoid growth requires epidermal growth factor and
R-spondin1, which enhances Wnt signaling via Lgr receptors (Figure 1.3; (Carmon et al.,
2012; de Lau et al., 2011)).

Figure 1.7 Intestinal organoid structure. Intestinal organoid forms new crypt-villus
axis by stem cell renewal and differentiation. Adapted from (Roeselers et al., 2013)

However,	
   intestinal	
   progenitor	
   cells	
   from	
   fetal	
   and	
   neonatal	
   intestine	
   grow	
  
into	
   undifferentiated	
   hollow	
   spheroids	
   in	
   the	
   same	
   culture	
   condition	
   (Figure	
   1.8;	
  
(Fordham	
  et	
  al.,	
  2013;	
  Mustata	
  et	
  al.,	
  2013)).	
  These	
  spheroids	
  are	
  morphologically	
  
similar	
   to	
   APC	
   null	
   adult	
   organoids,	
   but	
   express	
   low	
   level	
   of	
   Wnt	
   target	
   genes	
  
including	
  Lgr5	
  and	
  Axin2.	
  	
  
12	
  
	
  

Intestinal Organoids

Intestinal Spheroids

	
  
Figure 1.8 Intestinal organoids and spheroids. Intestinal spheroid consists of highly
proliferative cells without terminally differentiated cells. There is no crypt-villus domain
in intestinal spheroid. Adapted from (Fordham et al., 2013)

13	
  
	
  

1.4 Epigenetic regulations in the intestinal epithelium
	
  

While the signaling pathways and transcriptional regulators involved in intestinal
development and homeostasis have been investigated extensively, the role of epigenetic
factors in these processes is largely unknown. Epigenetics is defined as heritable
phenotypic traits, which affect gene function but are independent of alteration to the
DNA sequence itself (Jaenisch and Bird, 2003). Epigenetic control is important for the
establishment of cell-specific gene expression profiles and thus for self-renewal and
differentiation of stem cells (Spivakov and Fisher, 2007). There are two main
components of epigenetic modification - histone modifications and DNA methylation
(Figure 1.9).

Figure 1.9 Two main components of epigenetic modification. DNA methylation is a
process by which a methyl group is added to cytosine, mostly on cytosine-guanine
14	
  
	
  

dinucleotide. Histone modification is a covalent post-translation modification including
methylation and acetylation in globular domain or tail. Adapted from (Qiu, 2006).

DNA is wrapped around the histone octamer, which contains two copies each of
the histone proteins H2A, H2B, H3, and H4, and is packed into chromatin. The basic unit
of chromatin is the nucleosome that consists of 147 base pair of DNA and a histone
octamer (Luger et al., 1997). Post-translational modifications on histone proteins alter
DNA accessibility and transcription during cell fate determination by themselves, or by
recruiting effector proteins (Jenuwein and Allis, 2001; Tropberger and Schneider, 2013).
Methylation (Me) and acetylation (Ac) on lysine (K) residue of the histone 3 (H3) tail
have been the best characterized histone modifications to date. Although H3K4me3 and
H3K27me3 mark active and inactive genes, respectively, they are co-localized as bivalent
modifications at developmental genes poised for rapid activation following a
differentiation signal (Bernstein et al., 2006; Ringrose and Paro, 2004). With regards to
promoter-distal regulatory elements, H3K4me2 and H3K27Ac are enriched at active
enhancers, which are also frequently occupied by the histone acetyltransferase p300.
Poised enhancers have both H3K4me1 and H3K27me3, and are also often bound by the
Polycomb Repressive Complex 2 (PRC2) (Figure 1.10; (Zhou et al., 2011)).
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Figure 1.10 Histone modifications in gene regulation. H3K4me2 and H3K27Ac mark
active enhancers with the histone acetyltransferase p300, lineage-specific transcription
factors and RNA polymerase II, producing enhancer RNAs (eRNAs). Poised enhancers
have H3K4me1 and H3K27me3 with the Polycomb Repressive Complex 2 (PRC2), and
do not give rise to eRNAs. Repressed enhancers are enriched in H3K27me3 and PRC2,
and are characterized by dense nucleosome packing. Adapted from (Nguyen et al., 2015).

Genome-wide H3K4me2 profiles in Lgr5+ intestinal stem cells, secretory
progenitors, and enterocytes are relatively similar (Kim et al., 2014). This finding
suggests that enhancer chromatin is ‘open’ in any cell type of the intestinal epithelium,
but their activities might be regulated by other epigenetic modifications or transcription
factor bindings for proper differentiation.
Another major epigenetic modification is methylation at the 5-carbon of the
cytosine resulting in 5-methylcytosine (5mC). 5mC plays critical roles in many biological
processes such as gene silencing, genomic imprinting, and genomic stability by
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suppressing transposable and repetitive elements (Miranda and Jones, 2007). There are
three DNA methyltransferases (Dnmt), termed ‘Dnmt1, -3a and -3b’ in mammals.
Dnmt3a and -3b are classified as de novo methyltransferases and Dnmt1 is considered as
maintenance methyltransferase to copy methylation pattern to newly synthesized
daughter strands during replication, although this strict biochemically based classification
has been challenged recently by in vivo gene ablation studies (Elliott et al., 2016). Mice
with ablation of the Dnmt genes exhibit global hypomethylation, and embryonic lethality,
suggesting an essential role for methylation during development (Figure 1.11; (Bestor,
2000)).

Figure 1.11 De novo and maintenance DNA methylation. Initial methylation patterns
are established by the de novo DNA methyltransferases DNMT3A and DNMT3B during
early development, When DNA replication and cell division occur, the maintenance
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methyltransferase, DNMT1 maintains established methylation patterns in daughter cells.
Adapted from (Wu and Zhang, 2010).

Alterations of the DNA methylome during the process of differentiation of Lgr5+
intestinal stem into differentiated villus cells in adult mice have been reported recently
(Kaaij et al., 2013; Sheaffer et al., 2014). Genes highly expressed in Lgr5+ intestinal stem
cells, such as Olfm4 and ‘Hes family basic helix-loop-helix transcription factor 1’ (Hes1),
gain methylation while their expression is repressed in differentiated cells. Intestinal
enterocyte marker genes, such as alkaline phosphatase, intestinal (Alpi) and lactase (Lct),
lose DNA methylation during the differentiation process, which correlates with increased
binding of Cdx2 and its partner protein Hepatocyte Nuclear Factor 4α (Hnf4α), and
activation of gene expression in differentiated cells (Figure 1.12; (Kaaij et al., 2013;
Sheaffer et al., 2014)). Conditional deletion of Dnmt1 in the entire intestinal epithelium
or in Lgr5+ stem cells of adult mice leads to crypt expansion or altered stem cell
morphologies, respectively (Figure 1.12; (Sheaffer et al., 2014; Yu et al., 2015)).

Figure 1.12 DNA methylation changes in the intestinal epithelium. Lgr5+ intestinal
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stem cells (LGR5+ ISC), differentiated intestinal epithelial cells (DIFF IEC), and Dnmt1deleted intestinal epithelium (ΔDNMT1). Adapted from (Sheaffer et al., 2014)

Loss of Tcf4 correlates with increased methylation levels at the differentially
methylated regions, which are located near Tcf4 binding sites in intestinal crypt (Kaaij et
al., 2013; Schuijers et al., 2014; van Es et al., 2012a). These findings suggest that the
dynamics of DNA methylation plays an important role in enhancer activities, and is
associated with Wnt target genes in intestinal epithelial differentiation.
Loss of Dnmt1 in the developing intestine results in severe intestinal
abnormalities and partial lethality before weaning (Figure 1.13; (Elliott et al., 2015; Yu et
al., 2015)). These results demonstrate that DNA methylation plays an important role in
intestinal maturation and homeostasis.

Figure 1.13 DNA methylation is essential for the postnatal intestinal maturation.
Intestinal epithelium specific deletion of Dnmt1 in the developing intestine. Loss of
Dnmt1 shows villus atrophy and vacuolated cells in the intestinal epithelium of postnatal
day 7 mice. Adapted from (Yu et al., 2015)
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1.5 TET-mediated DNA hydroxymethylation in DNA demethylation pathway
	
  

DNA methylation is relatively stable epigenetic modification, but its levels are
tightly regulated during development (Reik et al., 2001). In primordial germ cells and
zygotes of mammals, for example, global 5mC decreases rapidly, suggesting a precise
mechanism of DNA demethylation. Ten-eleven translocation (TET) enzymes are
identified as dioxygenases that can convert 5mC to 5-hydroxymethylcytosine (5hmC) in
various mammalian cells such as embryonic stem cells, brain and bone marrow
(Kriaucionis and Heintz, 2009; Li and Liu, 2011; Tahiliani et al., 2009).
5hmC and TET enzymes are involved in both passive and active DNA
demethylation in mammals (Wu and Zhang, 2010). 5hmC can facilitate passive
demethylation during replication due to poor recognition of the 5hmC-modified DNA
segments by the maintenance DNA methyltransferase DNMT1 (Inoue and Zhang, 2011;
Valinluck and Sowers, 2007). In terms of active demethylation, TET enzymes are able to
further oxidize 5hmC to 5-formylcytosine (5fC) and 5-carboxycytosine (5caC), which are
excised by thymidine DNA glycosylase (TDG), followed by replacement of abasic sites
with unmethylated cytosines by the base excision repair pathway (Figure 1.14; (He et al.,
2011; Maiti and Drohat, 2011)). These findings suggest that 5hmC is the first step of
DNA demethylation and may be involved in transcriptional activation by removing
repressive 5mC (Ficz et al., 2011; Nestor et al., 2012).
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Figure 1.14 5mC oxidation and demethylation process. 5mC is generated by DNMT,
which can be oxidized by TET enzymes to generate 5hmC, 5fC and 5caC. All oxidative
derivatives can be diluted out during replication, due to lack of recognition of DNMT1
(Passive demethylation). 5fC and 5caC can be excised by TDG and repaired by the base
excision repair mechanism to C (Active demethylation). Adapted from (Ficz, 2015)

The mammalian Tet gene family has three members: Tet1, Tet2 and Tet3 (Ito et
al., 2010). All of Tet proteins contain a C-terminal catalytic domain that exhibits Fe2+ and
2-oxoglutarate-dependent dioxygenase activity and oxidize 5mC to 5hmC/5fC/5caC (Ito
et al., 2011). This catalytic domain is used for a targeted DNA demethylation at
endogenous loci by fusing to engineered transcription activator–like effector (TALE)
repeat arrays. TALE-TET catalytic domain fusion protein can lead to demethylation at
the targeted promoters in human cells and upregulation of endogenous human gene
expressions (Maeder et al., 2013).
Tet1 is highly expressed in ES cells and is required for normal ES cell
differentiation (Dawlaty et al., 2011; Ito et al., 2010). Tet1-/- mice on a mixed background
21	
  
	
  

are grossly normal, but have a smaller body size than litter mate controls during the
postnatal period and exhibit defects in memory function (Dawlaty et al., 2011; Rudenko
et al., 2013; Xin et al., 2015; Zhang et al., 2013). In contrast, a different allele of Tet1-/mice on a pure C57BL/6 background showed partial embryonic lethality, smaller body
size, and defects in fertility (Kang et al., 2015; Yamaguchi et al., 2012). Tet2-/- mice
develop abnormally high numbers of myeloid cells and blood cancer in adulthood. Tet2
loss in hematopoietic stem cells leads to increased stem cell self-renewal, DNA
hypermetylation at active enhancers and leukemogenesis (Ko et al., 2011; Moran-Crusio
et al., 2011; Quivoron et al., 2011; Rasmussen et al., 2015; Shide et al., 2012). Tet3-/mice show embryonic and neonatal lethality (Gu et al., 2011). Tet3 followed by Tet2 are
the most highly expressed Tet genes in the embryonic mouse brain, and their expression
levels are increased during neuronal differentiation along with the increase of 5hmC
levels. Loss of Tet3 and/or Tet2 causes a defect in neural progenitor cell maintenance and
differentiation during brain development (Hahn et al., 2013; Li et al., 2015; Lister et al.,
2013).
In chapter 2, I will present a novel role for TET1-mediated DNA
hydroxymethylation in Wnt target gene expression in intestinal maturation and
homeostasis.
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1.6 An Independent Role of 5hmC in Gene Regulation
	
  

The levels of 5hmC in various tissues is much greater than would be expected if it
were just an intermediate product in the DNA demethylation pathways, and are also
dynamically changed during differentiation and aging (Bachman et al., 2014; Szulwach et
al., 2011b; Tahiliani et al., 2009). Thus, 5hmC may be a new semi-stable epigenetic
mark, recruiting unique chromatin or transcriptional modifiers, and providing another
level of gene expression regulation (Frauer et al., 2011; Mellén et al., 2012; Spruijt et al.,
2013; Yildirim et al., 2011).
Although the enrichment 5hmC in promoters and gene bodies is correlated with
active gene expression (Figure 1.15; (Ficz et al., 2011; Song et al., 2010)), 5hmC is also
found at bivalent promoters of poised developmental genes (Figure 1.15; (Pastor et al.,
2011; Wu et al., 2011)). This indicates 5hmC may have a role in pausing or silencing
gene expression (Robertson et al., 2011; Szulwach et al., 2011a). Dual functions of 5hmC
in gene regulation could be explained by its key role as a central node in epigenomic
network in ES cells (Juan et al., 2016).
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Figure 1.15 The dual role of 5hmC and TET in gene regulation. 5hmC and TET
proteins may block DNMTs or Methyl-binding proteins to maintain unmethylated status
in active gene promoter. However, 5hmC and TET enzymes are also found in regulatory
regions of transcriptionally poised gene, interacting with the SIN3A co‐repressor
complex and PRC. Adapted from (Branco et al., 2012).

In chapter 3, I will present a repressive role for 5hmC at putative distal enhancers,
which is characterized by transcription factor bindings and absence of histone enhancer
marks, and suggests that 5hmC is a new epigenetic mark for silenced enhancers.
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2.1 Summary
	
  

Methylated cytosines are associated with gene silencing. The Ten-eleven
Translocation (TET) hydroxylases, which oxidize methylated cytosines to 5hydroxymethylcytosine (5hmC), are essential for cytosine demethylation. Gene silencing
and activation are important processes in intestinal stem cell (ISC) differentiation and
maintenance, but the potential role of TET hydroxylases in these processes has not yet
been examined. Here, we generate genome-wide maps of the 5hmC mark in ISCs and
their differentiated progeny. Genes with high levels of hydroxymethylation in ISCs are
strongly associated with Wnt signaling and developmental processes. We thus
investigated Tet1-deficient mice and found that they are growth-retarded, exhibit partial
postnatal lethality, and have significantly reduced numbers of proliferative cells in the
postnatal intestine. In the Tet1-deficient crypt, decreased expression of Wnt target genes
such as Axin2 and Lgr5 correlates with lower 5hmC levels at the promoter of Wnt target
genes. These data demonstrate that Tet1-mediated DNA hydroxymethylation plays a
critical role in the epigenetic regulation of the Wnt pathway in intestinal stem and
progenitor cells, and consequently in the self-renewal of the intestinal epithelium.
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2.2 Background

DNA methylation is a widespread epigenetic modification that regulates gene
expression in development and cellular differentiation (Reik et al., 2001; Sheaffer et al.,
2014; Smith and Meissner, 2013). DNA methylation is dynamic, yet tightly regulated to
prevent aberrant patterns of 5-methylcytosine (5mC), which are common in cancer
(Baylin et al., 2001; Esteller, 2007). 5mC is established and maintained by DNA
methyltransferase (DNMT) enzymes (Li et al., 1992; Okano et al., 1999). Recently,
oxidation of 5mC to 5-hydroxymethylcytosine (5hmC) by the Ten-eleven translocation
(TET) gene family was proposed as a novel mechanism for removal of 5mC (Kriaucionis
and Heintz, 2009; Tahiliani et al., 2009). This can occur by at least two non-mutually
exclusive mechanisms. First, 5hmC can be further oxidized to 5-formlyctosine (5fC) and
then 5-carboxylcytosine (5caC), again by the Tet enzymes, though at much lower
efficacy than oxidation from 5mC to 5hmC (Ito et al., 2011). Both 5fC and 5caC can be
glycosylated by thymine DNA glycosylase and replaced by unmodified cytosine via base
excision repair (Maiti and Drohat, 2011; Weber et al., 2016). Second, because
hemimethylated 5hmC nucleotides are not recognized by the maintenance DNA
methyltransferases following DNA replication during S-phase, hydroxymethylation of
specific sites will lead to their targeted, passive demethylation in replicating cells. Thus,
hydroxymethylation via the Tet enzymes offers an elegant pathway for even lineagecommitted cells to change their DNA methylation status.
Global methylome analyses in recent years have shown that the DNA methylation
status is dynamic with aging even within the same cell type (Avrahami et al., 2015).
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Likewise, we and others have demonstrated previously that DNA methylation at specific
loci changes during differentiation of intestinal stem cells (ISCs) to enterocytes in adult
mice (Kaaij et al., 2013; Sheaffer et al., 2014) and during ISC maturation in the postnatal
mice (Yu et al., 2015); however, how these elements are targeted for demethylation is
currently unknown.
The epithelium of the small intestine is the most rapidly self-renewing tissue in
mammals, and even in humans the epithelium is replaced every three to five days. Active
Wnt signaling in the intestinal crypt is a major driving force for intestinal stem cell
renewal and proliferation of transit-amplifying cells. Tight regulation of Wnt signaling is
critical for the intestinal epithelial homeostasis (Gregorieff and Clevers, 2005). Rapidly
cycling Lgr5+ stem cells at the bottom of the intestinal crypt give rise to transitamplifying cells that divide up to six times further (Rao and Wang, 2010) before
differentiating into post-mitotic, functional cells as they exit the crypt zone and migrate
up the crypt-villus axis. This process is accompanied by dramatic changes in the
transcriptional program, which are mediated, at least in part, by epigenetic changes such
as the aforementioned realignment of DNA methylation status (Kaaij et al., 2013;
Sheaffer et al., 2014). In fact, in the absence of Dnmt1 alone or both Dnmt1 and Dnmt3b,
the intestinal epithelium is not viable in the postnatal period (Yu et al., 2015) or in adult
(Elliott et al., 2016), respectively. Here, we investigate to what extent targeted oxidation
of 5mC to 5hmC contributes to intestinal epithelial health.
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2.3 Methods

Mice. All procedures involving mice were conducted under a protocol approved by the
Institutional Animal Care and Use Committee (IACUC) of the University of
Pennsylvania. Eight to twelve week-old C57BL/6J mice were used for all experiments
unless noted otherwise. For sorting of Lgr5+ stem cell, we employed Lgr5-EGFP-IresCreERT2 mice (Barker et al., 2007). Tet1-/- mice (Dawlaty et al., 2011) were backcrossed
to C57BL/6J mice for five generations. Eight week-old Tet1+/- mice were then
intercrossed to generate Tet1-/- mice. Pups were monitored for litter size and body weight
gain. Survival rate calculation and statistical analyses were performed using Prism
Graphpad software. Tet1+/- mice were crossed to Lgr5-EGFP-Ires-CreERT2 mice and
Tet1+/-;Lgr5-EGFP-Ires-CreERT2 mice were intercrossed to generated Tet1-/-;Lgr5EGFP-Ires-CreERT2 mice.

Dot Blot. For the analysis of hydroxymethylation levels, DNA samples were denatured at
95  °C for 10 min and spotted onto Hybond-N+ nitrocellulose membranes (GE
Healthcare). The membrane was blocked with CAS-Block (Thermo Fisher Scientific),
followed by overnight incubation with an anti-5hmC antibody (Active Motif) at 4°C.
Membranes were incubated with horseradish peroxidase (HRP)-conjugated goat antimouse antibodies (GE Healthcare) for 30 min at room temperature and developed using
the ECL+ prime blotting detection system (GE Healthcare).
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Immunohistochemistry. Dissected tissues were washed in cold PBS and fixed overnight
in 4% paraformaldehyde at 4°C before paraffin embedding. Antigen retrieval was
performed using Retriever in buffer A (Electron Microscopy Sciences), and tissue
sections were incubated overnight at 4°C with anti-5hmC (Active Motif), anti-Ki67 (BD
Pharmingen), anti-Axin2 (Abcam), anti-Sox9 (Millipore), anti-CyclinD1 (Biocare
Medical) and anti-GFP antibodies (Aves Labs). After incubation with secondary
antibodies (Vector Lab) for 2hrs at room temperature, samples were mounted in
fluorescent mounting medium (Dako) or developed using the Vectastain Elite ABC kit
(Vector Lab). Images were acquired using a Nikon Eclipse 80i fluorescence microscope
and a Leica SP8 confocal microscope.

Lgr5+ cell, crypt, and villus isolation. Small intestines were dissected and opened
longitudinally. The tissues were washed in cold PBS and scraped gently on the luminal
side with a glass slide to obtain villus cells. The remaining tissue was incubated with
rotation in 5mM EDTA/HBSS for 30 min at 4°C. After EDTA incubation, the tissue was
vigorously shaken for 15 seconds. The first fraction was villus-rich and thus discarded.
After further shaking, the supernatant enriched for intestinal crypts was passed through a
70 µm cell strainer to remove residual villus material and was centrifuged at 600 rpm for
2 min to collect crypts. For Lgr5+ cell sorting, isolated crypts were dissociated with
TrypLe express (Thermo Fisher Scientific) for 20 min at 37°C and shaken every 5 min to
prevent cell clumping. Dissociated cells were passed through a 40 µm cell strainer and
washed with HBSS. GFP+ cells were separated on a FACS Diva (BD Bioscience).
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DNA hydroxymethylation analysis. Genomic DNA was isolated from sorted Lgr5+
cells, crypt and villus cells using the AllPrep kit (Qiagen) and sonicated to an average
size of 150-300 bp (Covaris). DNA fragments were denatured (10  min at 95  °C) and
immunoprecipitated using 2µl of anti-5hmC antibody (Active Motif) and 10µl Protein G
beads (Thermo Fisher Scientific) in IP buffer (10 mM sodium phosphate, pH 7.0; 140
mM NaCl; 0.05% Triton X-100). For hMeDIP-qPCR, hydroxymethylated DNA and
input DNA were quantified on an Mx3005P qPCR System (Applied Biosystems) using
the Brilliant II SYBR Green QPCR master mix (Agilent). For hMeDIP-seq, DNA
fragments were ligated with Illumina adaptors using the NEBNext® DNA Library Prep
Master Mix Set (NEB). Following adaptor ligation, DNA fragments were denatured and
immunoprecipitated using an anti-5hmC antibody (Active Motif). Hydroxymethylated
DNA was amplified with adapter-specific primers (12 cycles). Amplified fragments
ranging from 150 to 200 bp were size-selected followed by sequencing on a HiSeq2000
(Illumina).

Mapping of sequencing data and bioinformatics. Reads were aligned to the mouse
reference genome (NCBI build 37, mm9) using Bowtie (Langmead et al., 2008). Only
unique reads were used for peak calling and annotation by HOMER (Heinz et al., 2010).
BedGraph files were generated and viewed on the UCSC Genome Browser.
Differentially hydroxymethylated Regions (DhMRs) were determined by comparing
5hmC peak levels in one sample to the other in each direction (fold change cutoff = 5, P
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value cutoff = 1.00 x 10-4). Gene ontology analysis was performed with DAVID (Huang
et al., 2009).

RNA isolation, qPCR, and mRNA-seq analysis. Total RNA and complementary DNA
(cDNA) were prepared using AllPrep kit (Qiagen,) and Superscript First-Strand synthesis
system (Thermo Fisher Scientific). RT-qPCR reactions were performed on an Mx3005P
qPCR System (Applied Biosystems) using Brilliant II SYBR Green QPCR master mix
(Agilent). Relative expression levels were determined using comparative Ct values after
normalizing to Tbp. RNA-seq method was previously detailed (Sheaffer et al., 2014).

Intestine organoid culture. Isolated intestinal crypts were resuspended in Matrigel
(Corning) and covered with standard EGF/Noggin/R-spondin medium (Sato et al., 2009).
Culture medium was changed every other day.
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Table 2.1 RT-qPCR primers
	
  

Gene

Strand

GAGCCTGTTCCTCGATGTGG

F
Tet1

CAAACCCACCTGAGGCTGTT

R

AACCTGGCTACTGTCATTGCTCCA

F
Tet2

ATGTTCTGCTGGTCTCTGTGGGAA

R

CCGGATTGAGAAGGTCATCTAC

F
Tet3

AAGATAACAATCACGGCGTTCT

R

TAAAGACGACGGCAACAGTG

F
Lgr5

GCCTTCAGGTCTTCCTCAAA

R

GAACAGGAACCAGAGCCCTTT

F
Creb3l3

CTCTGCATCTTCCTGGTGGTC

R

CGGAAAGTGGAATCCTTGCA

F
Vimentin

CACATCGATCTGGACATGCTGT

R

TGATGCTGAGAAGGCTGCTGTCTCTG

F
Hemoglobin β

GTGCCCTTGAGGCTGTCCAAGTGA

R
	
  

Sequence
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Table 2.2 hMeDIP-qPCR primers
	
  

Name
Lgr5
promoter

Genomic location
	
  

chr10:115,026,111
-115,026,229
	
  

Axin2
promoter

Sox9
promter

	
  

Strand

Sequence

F

AGGCCTGTTTTCAGTAAGTTTGTG
	
  
	
  
AAAGACCATGACTGCGCTCT

R

	
   ATTCGAAGGTGACAGTGGGG

F

chr11:108,780,916-‐
108,781,024	
  

chr11:112,641,826112,641,940

CACACTCTCCCAAAGGGCTG

R

CTCGTAAACAGGCTACAGGGT

F

TTGGGGAAAGGAACTCGTGA

R
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2.4 Results

5hmC level is high in intestinal villus epithelial cells
To determine global 5hmC levels in ISCs, we performed 5hmC dot blot analysis
of genomic DNA from isolated epithelial cells as well as brain and embryonic stem cells
(ESCs) for comparison. We found that 5hmC levels in the gut are almost as high as those
present in the brain and ESCs (Figure 2.1A). Hydroxymethylation of cytosines has been
suggested to play an important role in neurons due to the abundance of this mark in the
brain (Hahn et al., 2013; Rudenko et al., 2013). Therefore, we hypothesized that this
epigenetic mark might also play an essential role in intestinal epithelial cells. We
examined the distribution of global 5hmC compared to 5mC in the intestinal epithelium
by immunofluorescence detection of each mark with specific antibodies. 5mC was
present in all epithelial cells, with highest levels in the crypt where stem and transitamplifying cells reside (Figure 2.1B).

We identified proliferating stem and transit-

amplifying cells by co-staining with Ki67, a marker of proliferation. Interestingly, we
found that the strongest 5hmC signal was detected in the nuclei of differentiated villus
cells, while the signal decreased in the crypt region (Figure 2.1C). This finding is
consistent with previous reports that 5hmC is depleted in proliferating cancer cells
compared to post-mitotic cells (Jin et al., 2011; Lian et al., 2012).
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Figure 2.1 Differential enrichment of DNA methylation and hydroxymethylation in
the intestinal epithelium. (A) Dot blot shows global 5hmC levels in the mouse adult
intestinal epithelium compared to brain and embryonic stem cells (ESCs). (B-C)
Immunofluorescence staining of mouse jejunum with 5mC (B), 5hmC (C) and Ki67
antibodies as indicated. Scale bars: 50µm.

Dynamic changes of 5hmC distribution during intestinal epithelial differentiation
Next, we examined dynamic genomic 5hmC abundance during ISC
differentiation. First, we isolated Lgr5-expressing ISCs (Lgr5+) from Lgr5-EGFP-IRESCreERT2 mice (Barker et al., 2007) by FACS sorting and differentiated villus epithelial
cells by careful scraping of the luminal side of the gut tube (Figure 2.2; see detailed
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description in Experimental Procedures). Genomic DNA was then isolated from both cell
populations. To investigate genome-wide changes of the 5hmC mark between Lgr5+ and
differentiated cells, we performed hydroxymethylated DNA immunoprecipitation
followed by next-generation sequencing (hMeDIP-seq; see Experimental Procedures).

Figure 2.2 Isolation of Lgr5+ intestinal stem and villus differentiated cells. (A) FACS
plot to isolate Lgr5-EGFP+ cells and RT-qPCR validation for Lgr5 expression in GFP+
cells. (B) H&E staining image of scraped differentiated villus cells and RT-qPCR
validation for cell-specific marker genes (Creb3l3: Enterocyte, Vimentin: Mesenchymal
cells, Hemoglobin: red blood cells).
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Figure 2.3 Differential 5hmC distributions in intestinal stem and differentiated cells.
(A–C) Screenshots of bisulfite sequencing (with measures 5mC and 5hmC) and hMeDIPsequencing (5hmC) at marker genes in Lgr5+ intestinal stem cells (A), Wnt target genes
(B) and differentiated villus cells (C). Data are presented as % methylation for the
bisulfite-sequencing data, and as reads per million mapped reads (RPM) for the 5hmC
data.
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Remarkably, we discovered striking differences in 5hmC levels marker genes for
both ISCs and mature enterocytes (Figure 2.3). For example, high levels of 5hmC were
present near promoters and throughout the gene bodies of ISC-marker genes such as
Lgr5, Olfm4 and Msi1, and Wnt target genes such as Axin2, c-Myc and Sox9 in Lgr5+
cells but were decreased dramatically after differentiation into villus epithelial cells
(Figure 2.3A-B, Figure 2.4A-B). Conversely, genes expressed at high levels only in
differentiated cells, such as Alpi, Sis and Fabp1, were hydroxymethylated only in
differentiated cells (Figure 2.3C, Figure 2.4C).

Figure 2.4. Marker gene expression level in Lgr5+ stem and differentiated cells. (A)
RNA-seq results for intestinal stem cell marker genes (B) RNA seq results for Wnt target
genes (C) RNA-seq results for differentiated villus cell marker genes
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Having established that the 5hmC mark is dynamic for the nine genes described
above, we performed a genome-wide analysis of hydroxymethylation. We identified a
total of 33,183 5hmC-enriched regions (peaks) in Lgr5+ cells and 100,707 peaks in
differentiated cells using HOMER (Heinz et al., 2010) (Figure 2.5A), and about eightfold increase of 5hmC signal in differentiated cells relative to the 5hmC signal in Lgr5+
cells (Figure 2.5B). When comparing 5hmC peaks between the two cell populations, we
identified 10,450 differentially hydroxymethylated regions (DhMRs) (≥5 fold, p <
0.0001), and divided them into two groups – higher 5hmC in Lgr5+ DhMRs (n=2,537)
and higher 5hmC in differentiated cells (n=7,903) (Figure 2.6A). The two groups of
DhMRs displayed distinct genomic distribution patterns. While Lgr5+ DhMRs were
enriched in intergenic regions, those present in differentiated cells were more likely to be
located in gene bodies. We identified the closest gene for each DhMR and performed
gene ontology analysis for the differentially hydroxymethylated gene sets (Figure 2.6B).
The genes associated with higher 5hmC levels in Lgr5+ cells were involved in
‘developmental process’ and ‘cell differentiation’, primary functions of stem cells.
Conversely, the genes associated with higher 5hmC levels in differentiated cells were
enriched for genes that control metabolic processes and nutrient transport, major
functions of enterocytes. Thus, overall, high levels of hydroxymethylation correlated
positively with the gene sets expressed in either Lgr5+ stem cells or post-mitotic,
differentiated villus epithelial cells.
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Figure 2.5 Overall 5hmC levels in Lgr5+ stem cells and differentiated cells. (A) Total
number of 5hmC enriched regions (peaks) number counting and genomic distribution in
Lgr5+ stem and differentiated cells (≥ 4-fold enrichment over local tag count, p-value <
0.001). (B) The relative 5hmC signal of hMedIP-seq in Lgr5+ stem and differentiated
cells. The ratio of hMeDIP/Input reads numbers in DIFF was set to 100%.

Figure 2.6 Dynamics of 5hmC and gene expression changes during intestinal stem
cell differentiation. (A) Genomic distribution of differentially hydroxymethylated
regions (DhMRs). Upper pie chart: regions with 5hmC levels that are higher in Lgr5+
stem cells than in differentiated epithelial cells (DIFF) (at least 5 fold, p-value < 0.0001).
Lower pie chart: regions with 5hmC levels that are higher in differentiated epithelial cells
(DIFF) than in Lgr5+ stem cells (at least 5 fold, p-value < 0.0001). Circle size represents
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the total number of DhMRs in each group. (B) Gene ontology search results for genes
closest to DhMRs. (C) Differential gene expression of differentially hydroxymethylated
genes (≥1.5 fold change) during intestinal epithelial differentiation. RNA-seq data for
both cell populations are represented as reads per kilobase per million mapped read
(RPKM).

Next, we examined the correlation between differential hydroxymethylation and
differential gene expression, determined by RNA-seq (Sheaffer et al., 2014). Genes
enriched for the 5hmC mark in Lgr5+ stem cells (n=1,181), including ISC-marker genes
such as Olfm4, Lgr5 and Msi1, showed higher gene expression level in Lgr5+ stem cells
than in differentiated villus epithelial cells (Figure 2.6C, left). Conversely, genes enriched
for the 5hmC mark in differentiated cells (n=1,559) including villus differentiated cell
marker genes such as Alpi, Sis and Fabp1, exhibited increased expression in
differentiated cells (Figure 2.6C, right). Overall, gene expression changes correlated
strongly with 5hmC level variation during ISC differentiation. However, we also noted
some exceptions where gene expression levels were anti-correlated with 5hmC status.
5hmC has been reported to have a role in transcriptional repression in specific cases
including poised enhancers and promoters (Choi et al., 2014; Pastor et al., 2011; Wu et
al., 2011).

Tet1 is required for postnatal intestinal development
Having determined that hydroxymethylation is highly dynamic during
differentiation of ISCs into functional villus epithelial cells, we investigated which of the
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Tet enzymes is most likely controlling this process. We measured Tet1, 2 and 3 mRNA
expression levels in Lgr5+ stem and in differentiated villus cells by RT-qPCR (Figure
2.7). Tet1 was expressed at much higher levels in Lgr5+ stem cells than in differentiated
cells, while Tet2 and 3 showed the opposite pattern. These data suggested that Tet1 might
have an essential role in Lgr5+ ISC function.

Figure 2.7 Differential expression of Tet1-3 in Lgr5+ stem and differentiated cells.
Relative mRNA expression level of Tet1 (A), Tet2 (B) and Tet3 (C) in Lgr5+ stem and
differentiated cells. Relative to Tbp.

Next, we phenotyped Tet1 null mutant mice (Dawlaty et al., 2011) during
postnatal development, when gastro-intestinal function first becomes relevant (Table 2.3).
Strikingly, we found that Tet1-deficient mice were growth-retarded during the early
postnatal period (Figure 2.8A), exhibited a much smaller body size (Figure 2.8B), and
showed significant postnatal lethality (Figure 2.8C). In fact, viability of Tet1-/- mice was
already significantly impaired by postnatal day 3 (Figure 2.8D).
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Table 2.3 Previous and current studies of Tet1 null mice
Tet1 ablation studies

Allele

Background

Phenotype

(Dawlaty et al., 2011)
(Rudenko et al., 2013)

exon 4 deletion

129Sv, C57BL/6
Mixed

(Yamaguchi et al.,
2012)

gene-trap cassette
into the 1st intron

6X backcrossed
to C57BL/6

(Zhang et al., 2013)
(Xin et al., 2015)

exon 11-13
deletion

129Sv, C57BL/6
Mixed

viable, fertile, impaired
learning and short-term
memory

(Kang et al., 2015)

exon 9-10 deletion

C57BL/6

partial embryonic lethal,
hydrocephalus,
degenerated ovaries

Current work

exon 4 deletion

5x backcrossed
to C57BL/6

partial postnatal lethal,
intestinal defects

viable, fertile,
impaired memory
extinction
partial embryonic lethal,
reduces female germcell and fertility

	
  

Figure 2.8 Postnatal growth retardation and lethality of Tet1 null mice. (A) Tet1 null
mice are growth-retarded. Weight curve during the postnatal period, ** P-value < 0.01 by
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t-test. (B) Representative Tet1+/+ and Tet1-/- mice on postnatal day 11 (P11).	
  (C) Survival
curve during postnatal period, *** P-value < 0.001 by a Log-rank (Mantel-Cox) test. (D)
Reduced perinatal viability of Tet1 homozygous mutants. Mice were quantified on
postnatal day 3. *** P-value < 0.0005 (chi-square test)

The intestines of Tet1-deficient mice were thinner and shorter than those of wildtype littermates (Figure 2.9A). On histological examination, we found both villus length
and proliferating cell number per crypt to be significantly reduced in Tet1-null mice
compared to wild-type littermates (Figure 2.9B-D). Thus, Tet1 plays an important role in
the maturation of the postnatal intestine.

Figure 2.9 Developmental defects during postnatal intestinal maturation. (A)
Representative image of intestinal tracts of Tet1+/+ and Tet1-/- mice at one week of age.
(B) Histological analysis of Tet1+/+ and Tet1-/- jejunum of one week-old mice.
57	
  
	
  

Proliferating cells are marked by immunohistochemistry for Ki67 (dark brown signal).
Scale bars: 50µm (C) Villus length comparison between Tet1+/+ and Tet1-/- one week-old
jejunum (*** P-value < 0. 001). (D) Ki67+ cell number per crypt is reduced in one weekold Tet1-/- jejunum, compared littermate controls. (*** P-value < 0. 001).

Wnt target genes and Lgr5 expression in the postnatal intestine is dependent on Tet1
function
Since Wnt signaling is essential for intestinal maturation and proliferation, we
reasoned Wnt target gene expression might be affected in the Tet1-deleted intestine. To
examine Wnt target gene expression levels, we performed immunostaining for Wnt
molecules in one week-old Tet1-/- jejunum compared to wild-type littermate. Expression
of Wnt target genes such as Axin2, Sox9 and Cyclin D1 were clearly reduced in mutant
intestine (Figure 3.10).
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Figure 3.10 Decreased level of Wnt target gene expression in the postnatal Tet1 null
mice intestine. Immunofluorescence stains of Wnt target proteins such as (A) Axin2 (B)
Sox9 and (C) Cyclin D1 in postnatal day 7 Tet1+/+ and Tet1 -/- mice. Scale bars: 100µm

To evaluate the consequences of Tet1-deficiency on ISCs, we crossed Tet1 mutant
mice with Lgr5-EGFP-IRES-CreERT2 mice, which allows for the easy detection of
Lgr5+ stem cells via expression of EGFP. We found a dramatic reduction in the
frequency of Lgr5-EGFP positive cells in the crypt of the postnatal and adult Tet1-null
jejunum by immunofluorescence staining and FACS (Figure 3.11). Thus, Tet1 is required
for maintaining Wnt target gene expression and Lgr5 expression during intestine
maturation.
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Figure 3.11 Reduction of Lgr5 expression in Tet1 null mice intestine. (A) Decreased
Lgr5-EGFP expression levels in two-week old and two-month old Tet1 null jejunum as
detected by immunofluorescence stains of GFP (green). Scale bars: 20µm (B) FACS
analysis demonstrates loss of Lgr5-EGFP+ cells in two-month old Tet1-/- mice. (C)
Quantification of Lgr5-EGFP positive cell number in two-month old Tet1+/+ and Tet1 -/mice. *** P-value < 0.001 (n=4)

Decreased 5hmC levels at Wnt target loci leads to spheroid formation
Next, we investigated stem cell function using intestinal crypt culture. We found
significantly decreased mature organoid-forming efficiency and reduced level of Wnt
target/ISC marker gene expression in cultures derived from Tet1-deficient intestine
(Figure 3.12). This finding suggests that the state of postnatal crypt from Tet1-/- mice is
more close to fetal crypt than adult crypt (Fordham et al., 2013; Mustata et al., 2013).
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Figure 3.12 Mature organoid-forming potential is reduced in the absence of Tet1.
Images of intestinal organoid formation from two-week old Tet1+/+ and Tet1-/- jejunal
crypts. Scale bars: 10µm. (B) Quantification of intestinal organoid volume after nine days
of culture. ** P-value < 0.01 (n=3). (C) Ratio of mature budding organoids over total
organoids. * P-value < 0.05 (n=3). (D) Differential gene expression in Tet1 -/- premature
spheroid compared to Tet1+/+ mature organoid.

To ascertain if the decrease in Wnt target genes and Lgr5 expression in Tet1-/mice was caused by altered hydroxymethylation levels, we analyzed 5hmC levels at their
loci in control and mutant mice. We found significantly decreased 5hmC levels at their
promoter region in Tet1 null mice by 5hmC immunoprecipitation followed by qPCR
analysis (Figure 3.13), which correlated with decreased Wnt target genes and Lgr5
expression levels (Figure 3.10 and 3.11). This finding suggests that Tet1 is critical for
hydroxymethylation followed by demethylation to allow for full activation of Wnt target
and stem cell genes.
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Figure 3.13 Differential 5hmC level at the promoter of Wnt target genes. hMeDIPqPCR results at the promoter of Lgr5, Axin2, Sox9 in two-week old Tet1+/+ and Tet1-/crypts. * P-value < 0.05 (n=3).
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2.5 Discussion

In this study, we document dynamic changes of 5hmC at key gene loci during ISC
differentiation and report that Tet1-mediated hydroxymethylation is essential for ISC
function. 5hmC was enriched at promoters and gene bodies of highly expressed genes in
each cell type and may reverse the repressive effect of 5mC for gene activation. Tet1 was
expressed in ISCs, not in differentiated villus cells.
Tet1-/- mice on a mixed genetic background (129Sv, C57BL/6) were previously
reported to be viable and fertile with no morphological and growth abnormalities
(Dawlaty et al., 2011; Zhang et al., 2013), but adult Tet1-/- mice exhibited defective selfrenewal of neural progenitor cells (Rudenko et al., 2013; Xin et al., 2015; Zhang et al.,
2013) and hematopoietic stem cells (Cimmino et al., 2015). However, after backcrossing
onto the C57BL/6 background, we observed decreased postnatal viability and striking
intestinal defects in these mice. Recently, Kang and colleagues also reported that Tet1deficient C57BL/6 mice exhibit partial embryonic lethality and growth retardation (Kang
et al., 2015); however, intestinal health was not examined in the prior study. We found
that Tet1-/- mice showed shortened intestinal length, reduced proliferating cell number
and villus height in the postnatal intestine, which is similar to the phenotype seen in mice
with conditional deletion of Dnmt1 in the developing intestine using Dnmt1f/f; VillinCre
mice (Elliott et al., 2015; Yu et al., 2015).
Lgr5 is known as one of Wnt target gene and an adult stem cell marker gene in
the intestine (Barker et al., 2007), but a limited number of Lgr5+ cells are also presented
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in the intervillus zone of the developing intestine at E 16.5 (Kinzel et al., 2014). During
intestinal maturation in the postnatal period, these Lgr5+ cells are rapidly cycling at the
bottom of the crypt and clearly exhibit stem-cell properties at this stage (Kim et al.,
2012). Here, we show that 5hmC enrichment at Wnt target loci in Lgr5+ stem cells is
required for full activation of gene expression, and homozygous deletion of Tet1 causes
significantly decreased 5hmC levels at these loci, resulting in a dramatically reduced Wnt
target genes and Lgr5 expression during postnatal intestinal maturation. Importantly, loss
of Tet1 also impairs mature organoid-forming capacity and thus stem-cell function of
small intestinal crypts. In culture, intestinal spheroids were generated from fetal intestine,
and exhibited low level of Wnt target gene expression (Mustata et al., 2013), which is
similar to what we generated from Tet1-deleted postnatal intestine. Our data demonstrate
that Tet1-mediated conversion from 5mC to 5hmC is an important epigenetic mechanism
regulating expression of Wnt target genes including Lgr5 during postnatal intestinal
maturation.
The definitive role of Tet1-mediated DNA hydroxymethylation in the intestine
warrants further investigation using conditional gene ablation models. Nevertheless, our
results demonstrate that 5hmC is an essential epigenetic mark required for ISC function.
DNA hydroxymethylation could be a switch to activate key genes in stem cells and
represents a novel mechanism of gene regulation during stem cell differentiation.
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CHAPTER 3

5-hydroxymethylcytosine represses the activity of enhancers in embryonic stem
cells: a new epigenetic signature for gene regulation
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3.1 Summary
	
  

Recent mapping of 5-hydroxymethylcytosine (5hmC) provides a genome-wide
view of the distribution of this important chromatin mark. However, the role of 5hmC in
specific regulatory regions is not clear, especially at enhancers. We found a group of
distal transcription factor binding sites highly enriched for 5-hydroxymethylcytosine
(5hmC), but lacking any known activating histone marks and being depleted for nascent
transcripts, suggesting a repressive role for 5hmC in mouse embryonic stem cells
(mESCs). 5-formylcytosine (5fC), which is known to mark poised enhancers where
H3K4me1 is enriched, is also observed at these sites. Furthermore, the 5hmC levels were
inversely correlated with RNA polymerase II (PolII) occupancy in mESCs as well as in
fully differentiated adipocytes. Interestingly, activating H3K4me1/2 histone marks were
enriched at these sites when the associated genes become activated following lineage
specification. These putative enhancers were shown to be functional in embryonic stem
cells when unmethylated. Together, these data suggest that 5hmC suppresses the activity
of this group of enhancers, which we termed “silenced enhancers”. Our findings indicate
that 5hmC has a repressive role at specific proximal and distal regulatory regions in
mESCs, and suggest that 5hmC is a new epigenetic mark for silenced enhancers.

Keywords
5hmC, GROseq, PolII, eRNA, mESC, Enhancer	
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3.2 Background
	
  

5-hydroxymethylcytosine (5hmC) is an epigenetic mark that arises from oxidation
of 5-methylcytosine (5mC) by Ten-eleven translocation (Tet) enzymes(Tahiliani et al.,
2009; Williams et al., 2011). The 5hmC mark has been studied in several cell types, such
as mouse embryonic stem cells (mESCs) (Tahiliani et al., 2009; Yu et al., 2012),
neuronal cells (Kriaucionis and Heintz, 2009; Mellen et al., 2012; Szulwach et al., 2011)
and adipocytes (Serandour et al., 2012). 5hmC is enriched at promoters marked
bivalently by H3K4me3 and H3K27me3 in mESCs (Matarese, 2011), but depleted at
promoters in the brain (Szulwach et al., 2011). 5hmC is also enriched at specific
transcription factor binding sites (TFBSs) in human and mouse ESCs (Ficz et al., 2011;
Pastor et al., 2011; Stroud et al., 2011; Szulwach et al., 2011; Williams et al., 2011; Wu
et al., 2011; Xu et al., 2011). Specifically, in mESCs, 5hmC is depleted at Sox2 and Oct4
binding sites, but enriched for Esrrb and Tcfcp2l1 occupancy (Wu et al., 2011). In human
embryonic stem cells (hESCs), 5hmC is highly enriched at CTCF, Nanog, and Oct4
binding sites (Stroud et al., 2011). Another study in hESC observed that the 5hmC profile
showed a bimodal distribution at Oct4, Sox2, TAF1 and p300 binding sites (Szulwach et
al., 2011). While these studies suggest a possible regulatory role for 5hmC at promoters
and TFBSs, its function at these regulatory regions remains unclear.
Here, we report on a new repressive role for 5hmC at specific regulatory regions
in mESCs. We show that 5hmC negatively correlates with nascent transcripts, especially
at TFBSs. Interestingly, we discovered that a group of distal TFBSs displays a new
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epigenetic signature; these sites are exclusively enriched for 5hmC, depleted for
activating histone modification marks (H3K4me1 and H3K27ac), and significantly
reduced for nascent transcripts or enhancer RNAs (eRNAs). The expression of the genes
close to these TFBSs was significantly lower than that of genes close to other classes of
TFBSs. In addition, we found that a fraction of these TFBSs becomes enriched for
activating histone marks (H3K4me1/2) in neural progenitor cells (NPCs) or
endomesoderm cells. RNA polymerase II (PolII) chromatin interaction analysis with
paired-end tagging (ChIA-PET) (Zhang et al., 2013) showed that the target genes of these
regulatory regions were indeed significantly upregulated in NPCs. Enhancer/luciferase
reporter assays demonstrated that these regions function as in gene activation when 5hmC
is removed for these sites. Together, our findings suggest that 5hmC is as a novel marker
for transcriptional silent enhancers in mESCs for regulatory regions that are activated
during development.
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3.3 Methods

Experimental procedures
We used genome-wide GROseq maps (Min et al., 2011) and ChIP-seq data for
chromatin status (Meissner et al., 2008; Mikkelsen et al., 2007), PolII occupancy
(Mikkelsen et al., 2007), 5mC (Ficz et al., 2011), and Tet1 occupancy (Ficz et al., 2011)
in mESCs for our integrated analysis. We employed H3K4me1/2 data from NPC
(Mikkelsen et al., 2007) and endomesoderm cells (Yu et al., 2013) to analyze the fate of
our novel 5hmC regions after differentiation. We also included 5hmC from various
independent studies (Pastor et al., 2011; Tan et al., 2013; Williams et al., 2011; Wu et al.,
2011; Wu and Zhang, 2011; Xu et al., 2011) for our analysis. Table 3.1 summarizes all
genome-wide datasets we used in our study.
All ChIP-seq data were normalized to 10 reads per kilobase per million mapped
reads (RPKM) (Mortazavi et al., 2008). For clustering analysis we used Mev V4.8 (Saeed
et al., 2006) and applied the K-means clustering algorithm using the Pearson correlation
with absolute distance as a metric. To cluster distal TFBs in mESCs, we used the
H3K4me1/2/3, H3K27ac, H3K27me and 5hmC levels and generated applied clustering
(K  =  10). We showed other epigenetic marks and GROseq and PolII next to the identified
clusters.
To study the functional roles of 5hmC in various regulatory regions, we employed
binding site data of 13 TFs (Nanog, Oct4, STAT3, Smad1, Sox2, Zfx, c-Myc, n-Myc,
Klf4, Esrrb, Tcfcp2l1, E2f1 and CTCF) in mESC (Chen et al., 2008).
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To investigate 5hmC and nascent RNA levels across genes, we divided the genes
into promoter (from -1Kbp to 500 bp around the annotated start site), 3′ end (from
−500 bp to 500 bp around the annotated termination site), and gene body regions (500 bp
from the annotated start site to −500 bp from the annotated termination site). For
transcription levels, we calculated RPKM using GROseq reads from 500 bp of the
annotated start site to the annotated termination site in order not to include transcriptional
pausing at promoters (Core et al., 2008; Rahl et al., 2010).

Luciferase reporter assay
Genomic DNA was prepared from R1 mouse embryonic stem cells(Nagy et al.,
1993). About 600 bp genomic fragments for five distal TFBSs in cluster 2 were amplified
by PCR with dNTPs and the PCR products ligated into the pGL3-SV40 luciferase vector
(Promega). Empty vector (control) or cloned vectors were transfected directly into R1
mESC, together with the pRL-tk vector (Promega) as internal control, using
Lipofectamine LTX (Life Technologies). At 24 h after transfection, cells were harvested
and lysates subjected to the dual-luciferase reporter assay (Promega). Firefly luciferase
activity was measured and normalized to the internal control, Renilla luciferase activity.

Table 3.1. Datasets.

Cell type

GEO accession
number

Data type
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Reference

mESCs (E14)

ChIP-seq (Nanog, Oct4,
STAT3, Smad1, Sox2, Zfx, cMyc, n-Myc, Klf4, Esrrb,
Tcfcp2l1, E2f1 and CTCF)

GSE11431

mESCs (E14)

MeDIP-seq : 5mC
ChIP-seq : H3K27ac

GSE38596
GSE36114

mESC (E14)
NSC, NPC

ChIA-PET

GSE44067

mESC(E14)Endomesoderm

ChIP-seq : H3K4me1,
H3K4me2

GSE36114
GSE38596

mESCs( E14TG2a.4)

5hmC (Williams)

GSE24841

mESCs(E14Tg2A)

Bisulfite-seq : 5hmC

GSE36173

mESCs(J1/E14)

TET1,MeDIP-Seq: 5hmC

GSE28500

(Cortellino et
al., 2011)

mESCs (J1)

MeDIP-Seq: 5mC, 5hmC

EBI: EPR000570

(Cortellino et
al., 2011)

mESCs (V6.5)

GROseq

GSE27037

mESCs (V6.5)

ChIP-seq : H3K4me1,
H3K4me2, H3K4me3,
H3K27me3, PolII

GSE11172
GSE12241

mESCs (V6.5)

5hmC(Pastor)-GLIB
5hmC(Pastor)-CMS

GSE28682

mESCs(V6.5)

RNA-seq : Tet1kd, Tet2kd

GSE50198

mESCs (Tdgfl/fl)

5fC

GSE41545

(Song et al.,
2013)

mESCs(46C)

MeDIP-Seq : 5hmC (Tan)

GSE40810

(Tan et al.,
2013)

mNPCs

MeDIP-Seq : 5hmC (Tan)

GSE40810

(Tan et al.,
2013)

Mouse adipocyte
(3T3L1)

ChIP-seq : PPARγ, PolII

GSE13511

Bisulfite-seq : 5hmC

GSE36173

H3K4me1, H3K27ac, DNaseI

ENCODE

GROseq

GSE41009

hESCs (H1)
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(Chen et al.,
2008)

(Yu et al.,
2012)
(Xiao et al.,
2012)
(Zhang et al.,
2013)
(Xiao et al.,
2012)
(Williams et
al., 2011)
(Yu et al.,
2012)

(Min et al.,
2011)
(Meissner et
al., 2008;
Mikkelsen et
al., 2007)
(Pastor et al.,
2011)
(Huang et al.,
2014)

(Nielsen et
al., 2008)
(Yu et al.,
2012)
(Bernstein et
al., 2010)
(Sigova et al.,
2013)

3.4 Results

A group of 5hmC-enriched distal TFBSs is lacking activating histone marks and
nascent RNA transcription
A recent survey had found 5hmC enriched at TFBSs in hESC (Stroud et al.,
2011), mouse neuronal cells, and adipocytes (Serandour et al., 2012). Therefore, we
investigated 5hmC levels (Xu et al., 2011) at the binding sites of 13 key transcription
factors (TFs) (Nanog, Oct4, STAT3, Smad1, Sox2, Zfx, c-Myc, n-Myc, Klf4, Esrrb,
Tcfcp2l1, E2f1 and CTCF) in mESC (Chen et al., 2008). We confirmed previous results
(Stroud et al., 2011; Wu et al., 2011) that 5hmC was generally depleted at the core of the
proximal (within 2 kb to transcription start sites (TSSs)) TFBSs, but relatively high in the
regions neighboring (±2 kb) the core (Figure 3.1A). We also confirmed that 5hmC is
highly enriched at the core of distal binding sites of many TFs, such as Zfx and Esrrb
(Figure 3.1B; (Stroud et al., 2011; Wu et al., 2011)).
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Figure 3.1 5hmC profile at promoters and enhancers. (A) The average profiles of
5hmC at promoter-proximal TFBSs. 0 represent the center of the TFBSs. (B) The average
profile of 5hmC at 13 TFBSs in promoter-distal (>2kbps) regions.

To further investigate the role of 5hmC in gene regulation in conjunction with
other epigenetic marks, we performed an integrative analysis using 5hmC, 5mC (Xu et
al., 2011), Tet1 (Ficz et al., 2011), H3K4me1/2/3, H3K27me3, RNA polymerase (Pol) II
occupancy (Mikkelsen et al., 2007) and nascent RNAs from global run-on sequencing
(GROseq) (Min et al., 2011)data. We found that 5hmC levels were inversely correlated
with nascent RNA transcription and Pol II occupancy at proximal TFBSs (Figure 3.2).
We confirmed the levels of 5hmC positively correlated with the levels of the repressive
H3K27me3 histone mark at proximal TFBSs (Matarese, 2011; Wu et al., 2011).

Figure 3.2 5hmC and other epigenetic modifications in ESCs. (A) Correlation
between 5hmC and various marks. The TFBSs were sorted based on the 5hmC levels in
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±2 K regions relative to the center of the binding sites. 5hmC levels at promoter-proximal
TFBSs were positively correlated with H327me3 levels and inversely correlated with
GROseq and PolII levels. Transcription levels of the genes associated with the promoter
were calculated using GROseq . In the sorted list, we averaged the transcription levels of
the adjacent 100 genes. (B) Clustering results of 5hmC with other epigenomic data at
distal (>2kbp from known TSSs) TFBSs. Cluster 1, 8 and 10 are enriched for H3K4me3
and GROseq, showing the properties of promoters. Cluster 5 and 9 display high levels of
H3K27ac, indicative of active enhancers. Cluster 2 is enriched for 5hmC and 5fC, has
very low GROseq levels, and lacks all investigated histone marks.

To study the epigenetic landscapes surrounding distal TFBSs, we applied the Kmeans algorithm (K  =  10) and found clusters marked by various epigenetic modifications
(Figure 3.2B). Clusters 1, 8 and 10 showed the properties of active promoters:
H3K4me2/3 enrichment with relatively low levels of H3K4me1 and the presence of
nascent RNA transcripts. These clusters thus likely represent the promoters of long
intergenic non-coding RNAs (Guttman et al., 2009) or un-annotated promoters of
protein-coding genes. Clusters 5 and 9 showed H3K4me1 and H3K27ac enrichment,
indicating active enhancers. These clusters, as well as clusters 3, 4, 6, and 7, showed only
a small amount of nascent transcripts or enhancer RNAs (eRNAs), which have been
known to correlate with the gene transcription levels of adjacent genes (Core et al., 2008;
Wang et al., 2011). The presence of eRNAs in these clusters suggest that the TFBS at
these clusters have an activating role.
We were especially interested in cluster 2, which was enriched for 5hmC, but was
depleted of eRNAs. Strikingly, this cluster had no activating histone marks such as
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H3K4me1 or H3K27ac (Creyghton et al., 2010; Heintzman et al., 2007; Rada-Iglesias et
al., 2011), even though TFs bind at these sites (Figure3.2B and Figure 3.3). 5mC was
depleted at the core of the TFBS, consistent with the previous observation in hESCs
(Lister et al., 2009). Compared with other clusters, cluster 2 was characterized by low
levels of eRNAs and low PolII occupancy. To confirm the enrichment for 5hmC, we
investigated the profile of sequencing data from other independent studies (Pastor et al.,
2011; Tan et al., 2013; Williams et al., 2011; Wu et al., 2011; Wu and Zhang, 2011; Xu
et al., 2011). Cluster 2 was enriched for 5hmC consistently for all four independently
measured datasets (Figure 3.4). We also examined TAB-seq, which provides baseresolution sequencing of 5hmC in mESC (Yu et al., 2012). The TAB-seq profile also
confirmed enrichment for 5hmC at the core of TFBSs for cluster 2 regions for both
strands (Figure 3.5). Together, these data suggest that 5hmC combined with absence of
H3K4me1 at distal TFBSs marks inactive enhancers.
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Figure 3.3 Comparison of the characteristics of each cluster. We plotted the levels of
H3K4me1/2/3, H3K27ac, H3K27me3, 5mC, 5hmC, GROseq, PolII and 5fC for all
clusters. Cluster2 is significantly enriched with 5hmC and 5fC, but depleted for enhancer
marks (H3K4me1/2, H3K27ac), eRNA (GROseq) and PolII. The high level of 5mC is
due to the enrichment for 5mC at the regions flanking the TFBSs.

Figure 3.4 Comparison of the 5hmC patterns for each cluster. 5hmC data were
obtained from (Pastor et al., 2011; Tan et al., 2013; Williams et al., 2011; Wu et al.,
2011; Wu and Zhang, 2011; Xu et al., 2011). Cluster 2 shows consistent enrichment of
5hmC for all four independent studies.
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Figure 3.5 The 5hmC profile of cluster 2 using TAB-Seq. The average profiles of
5hmC were generated using TAB-Seq data in mESC. 5hmC is enriched at the center of
TFBSs for both strands.

Surprisingly, cluster 2 is also highly enriched for 5-formylcytosine (5fC)
compared with other clusters (Figure 3.2B). Both 5fC and 5hmC are involved in the
active demethylation pathway (Ito et al., 2011; Maiti and Drohat, 2011). Previous
genome-wide study using 5fC revealed that 5fC is enriched at enhancers, especially at
poised enhancers marked by H3K4me1 without H3K27ac (Song et al., 2013). However,
the properties of the cluster 2 regions are novel, as they lack the H3K4me1 mark. This
strongly suggests that 5hmC as well as 5fC mark a novel type of “poised” or silenced
enhancer at distal regulatory regions where active histone modification marks are absent.
Next, we interrogated the state of the 5hmC mark in other cell types. In hESCs,
we also identified a cluster enriched for 5hmC (Yu et al., 2012) but depleted for both
H3K4me1 and H3K27ac at distal DNaseI hypersensitive sites (DHSs) (Figure 3.6;
(Bernstein et al., 2010)). As in mESCs, GROseq levels in hESCs (Sigova et al., 2013)
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were significantly weaker in this cluster (p-value  =  1.7e-14). In mature adipocytes, we
observed 5hmC (Serandour et al., 2012) enriched at over 20% of PPARγ binding sites
(Figure 3.7;(Nielsen et al., 2008)). Surprisingly, PolII occupancy (Nielsen et al., 2008)
was depleted when 5hmC was enriched (Figure 3.7). These data indicate that 5hmC can
be a repressive mark at distal regulatory regions regardless of cell type or differentiation
state.

Figure 3.6 The 5hmC clusters in hESCs. We performed clustering using 5hmC (Yu et
al., 2012), H3K4me1 and H3K27ac at distal DHSs in hESCs (Bernstein et al., 2010) and
identified 2 groups. Among 72,395 distal DHSs, we identified 8,034 sites (Group 1)
enriched for 5hmC, while H3K4me1 and H3K27ac were depleted. GROseq levels
(Sigova et al., 2013) were significantly weak in this cluster.
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Figure 3.7 The 5hmC clusters in mature adipocytes. We clustered 5hmC (Serandour et
al., 2012) with PolII (Nielsen et al., 2008) using the K-means clustering (K=4) algorithm
at distal PPARγ binding sites (Nielsen et al., 2008). 5hmC and PolII were exclusively
observed at these enhancers.

Table 3.2 lists the number of binding sites for each TF in cluster 2 in mESCs. The
majority of the cluster 2 regions were bound by CTCF, Tcfcp2l1 or Esrrb. Fewer binding
sites for Oct4, Sox2, and Nanog, the master regulators for self-renewal and pluripotency
in ESCs, were observed in cluster 2 (Boyer et al., 2005). This is consistent with the
observation that 5hmC is depleted at highly active enhancers in ESCs. We further
investigated if ChIP intensity is lower for the TFBSs in cluster 2. We did not find
statistical differences, even though the average profiles of the TFBSs in cluster 2 were
slightly lower compared with the TFBSs in other clusters (Figure 3.8).
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Table 3.2 The frequency of transcription factor occupancy in cluster 2.
Hyper-geometric p-values were calculated.
Number of TFBSs in

Total number of distal

Ratio

p-value

cluster 2

TFBSs in mESCs

CTCF

2,728

27,051

10.08%

<1e-130

E2f1

73

9,730

0.75%

1

Esrrb

1,004

14,102

7.12%

4e-24

Klf4

108

5,752

1.88%

1

cMyc

5

861

0.58%

1

nMyc

24

2,158

1.11%

1

Nanog

128

8,912

1.44%

1

Oct4

33

2,674

1.23%

1

Sox2

29

3,919

0.74%

1

Smad1

2

1,032

0.19%

1

STAT3

33

1,867

1.77%

1

Tcfcp2l1

1,026

17,881

5.73%

0.0017

Zfx

85

3,881

2.19%

1
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Figure 3.8 The average profiles of TFs at cluster 2. The average profiles of 13 TFs in
cluster 2 and other clusters. The p-value from t-test was calculated using the signals
around ±100bps. The significant p-values for Smad1 is because of the low number (2) of
binding sites and for E2f1 the flanking signals around the binding sites.
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5hmC-enriched distal TFBSs are associated with developmental genes
Next, we analyzed the correlation between 5hmC levels and transcriptional
activity of the genes closest to the TFBSs for each cluster. To calculate gene transcription
levels, we calculated the reads per kilobase per million mapped reads (RPKM) from
GROseq (see Methods). The genes mapping to the TFBSs in cluster 2 had strikingly
reduced transcription levels compared to the genes in all other clusters (p-value <1.3e20), even compared to clusters 8 and 10, where the repressive H3K27me3 mark was
relatively enriched (Figure 3.9A). GO analysis of the genes closest to the TFBSs in
cluster 2 using GREAT (McLean et al., 2010) revealed that the genes in this cluster were
enriched for developmental functions, such as “muscle cell development” (pvalue  =  3.4e-14)” and “foregut morphogenesis” (p-value  =  5.8e-9) (Figure 3.9B). This is
consistent with the fact that these genes are silent in ESCs and are only activated once
differentiation commences.
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Figure 3.9 Functional analysis for TFBSs with 5hmC. (A) Comparison of the
transcription levels of the nearest genes between cluster 2 and the other 9 clusters of
distal TFBSs identified in Figure 3.2B. The transcription levels (RPKM) were calculated
using GROseq data. (B) GO analysis for the genes close to TFBSs in cluster 2. Organ
development terms are enriched.

A snapshot in Figure 3.10 shows the enrichment for 5hmC at the Klf4 and the
Esrrb binding sites located in the first intron of Sorcs2. Sorcs2 is highly expressed in the
developing and mature murine central nervous system (Rezgaoui et al., 2001). We
observed that Sorcs2 is silent in mESC, and its promoter is bivalently marked by
H3K4me3 and H3K27me3 (Mikkelsen et al., 2007). In mouse neural progenitor cells
(NPCs), however, Sorcs2 is highly expressed (Mikkelsen et al., 2007). The Klf4 and the
Esrrb binding sites are marked by H3K4me1 in NPCs, suggesting an active role of this
region as an enhancer during neural development.
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Figure 3.10 Chromatin organization at the Sorcs2 gene in mESCs. The Klf4 and the
Esrrb binding sites in the intron of Sorcs2 gene are enriched for 5hmC. These binding
sites are depleted with H3K4me1 in mESCs, but are enriched in NPCs.

5hmC-enriched distal TFBSs become activated during development in a lineagespecific way
Because of the coordination of high 5hmC levels with low expression of genes in
cluster 2, we hypothesized that 5hmC may attenuate enhancer activity in mESCs, which
becomes activated later during development. Therefore, we analyzed H3K4me1/2 data in
NPCs (Mikkelsen et al., 2007) and endomesoderm cells (Yu et al., 2013). H3K4me1 and
H3K4me2 are known to mark enhancers (Heintzman et al., 2007). While H3K4me1/2
enhancer marks were depleted in mESCs, around 9% of distal TFBSs (out of 5,278
TFBSs) showed enriched H3K4me1/2 occupancy in NPCs, and an additional 20% of
TFBSs were enriched for H3K4me1/2 in endomesoderm cells (Figure 3.11). Overall,
5hmC levels were significantly decreased in cluster 2 regions after differentiation into
NPCs (Tan et al., 2013). This finding suggests that a group of 5hmC-enriched enhancers
are repressed in mESCs, but selectively become activated during development towards
the neuronal or endomesoderm lineage. This implies that other regions in cluster 2 might
be activated when ESCs are differentiated into other lineages such as primordial germ
cells.
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Figure 3.11 Lineage specific activation of distal TFBSs in cluster 2. (A) The enriched
H3K4me1/2 in NPCs or endomesoderm cells suggests the potential lineage specific
enhancer activation of the TFBSs in cluster 2 after differentiation. (B) The target genes of
cluster 2 in NPCs identified using ChIA-PET become significantly upregulated (p-value:
0.04) when they gained interactions. The expression change in MEF is compared as a
control (p-value: 0.12).

To further determine if the TFBSs in cluster 2 have activating roles in a lineagespecific way, we used chromatin connectivity maps from chromatin interaction analysis
with paired-end tagging (ChIA-PET) associated with PolII in ESCs and NPCs (Zhang et
al., 2013). By using the chromatin interaction information, we mapped the target genes of
the TFBSs in cluster 2 that were only selectively activated in NPCs. The target genes in
ESCs were slightly downregulated in NPC (as well as in mouse embryo fibroblasts
(MEFs)) because only a small portion of them become activated in a lineage-specific
manner as shown in Figure 3.11A. In contrast, the target genes in NPCs become
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significantly upregulated during the transition from ESCs to NPCs (p-value <0.05).
Moreover, the changes were significant compared with the target genes for clusters (all pvalues were <0.02) (Figure 3.12). This further supports the notion that TFBSs in cluster 2
become activated in a lineage specific way following embryonic stem cell differentiation.

Figure 3.12 The gene expression change for the target genes for each cluster. Using
ChIA-PET, we obtained the target genes in ESCs and in NPCs. The genes with
interacting chromatin in ESCs overall down-regulated. The target genes of cluster 2
significantly upregulated compared with other clusters (all p-values<0.02). (* if pvalue<0.001 and ** if p-value <0.0001)
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Cluster 2 regions show enhancer activity in mESCs when devoid of 5hmC
Next, we directly determined if lack of 5hmC activates enhancer activity of the
distal TFBSs in mESCs. We selected five highly 5-hydroxymethylated distal TFBSs
regions from cluster 2, including the site in Sorcs2 (TFBS1). This site is also enriched for
ChIA-PET (Zhang et al., 2013) reads. We amplified these sequences (±600 bp) by PCR
and subcloned them into luciferase reporter plasmids containing a minimal promoter. We
found that these DNA sequences indeed possess enhancer activity in mESCs when
lacking 5hmC, showing on average 3-fold increased luciferase activity compared to
control (Figure 3.13). This in vitro study suggests that 5hmC-enriched distal TFBSs are
bona fide enhancers, which are silent in mESCs when marked with 5hmC.

Figure 3.13 Enhancer activity of distal TFBSs lacking 5hmC in mESCs.
(A) Schematic diagram of the experimental setup. (B) Luciferase reporter assay for
5hmC-enriched putative enhancer regions (about 600 bp) including distal TFBSs in
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mESCs. Control: empty vector, TFBS1: 5hmC-enriched Klf4/Esrrb binding site (Figure
3.10), TFBS2: 5hmC-enriched Esrrb/Tcfcp2I1 binding site, TFBS3: 5hmC-enriched
Tcfcp2I1 binding site, TFBS4: 5hmC-enriched E2f1 binding site, TFBS5: 5hmCenriched Nanog/Sox2. The normalized luciferase activity of control is set as 1. *pvalue  <  0.05.

We also investigated if 5hmC at distal regulatory regions has a repressive role
using the Tet1 shRNA suppression experiments in mESCs (Huang et al., 2014). We
found that the target genes of cluster 2 were significantly upregulated (p-value  <  0.01)
after Tet1 gene suppression, suggestive of repressive roles of 5hmC (Figure 3.14). We
did not find a similar pattern in Tet2 shRNA-treated mESCs, possibly due to the fact that
Tet2 is dominantly associated with the 5hmC present in gene bodies (Huang et al., 2014).

Figure 3.14 The gene expression changes of the target genes after Tet1 knockdown
for each cluster. Fold changes were calculated using RNAseq data after Tet1
knockdown in mESCs (Huang et al., 2014). After knockdown of Tet1, the changes were
significant in cluster 2 (p-value: 0.006). For other clusters, p-value>0.01.
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Figure 3.15 The 5hmC in mESC and NPC at the TFBSs in mESCs. TFBS from all
clusters (except for cluster 2) were sorted based on the 5hmC levels in NPC. We used
5hmC in mESCs and NPC from (Tan et al., 2013).

	
  

Figure 3.16 5hmC at CTCF binding sites in cluster 2. 5hmC levels were shown at the
CTCF binding sites in cluster 2. After differentiation into NPCs, 5hmC become depleted.
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3.5 Discussion

The field of DNA methylation has expanded recently, with the identification of
multiple cytosine variants; 5hmC, 5fC, and 5-carboxylcytosine (5-caC) (He et al., 2011;
Ito et al., 2011). Among the cytosine variants, 5hmC has been most extensively studies
(Ficz et al., 2011; Pastor et al., 2011; Stroud et al., 2011; Szulwach et al., 2011; Williams
et al., 2011; Wu et al., 2011; Xu et al., 2011; Yu et al., 2012). Although there are
genome-wide 5hmC maps in several cell types, our understanding about the functional
role of 5hmC remains limited.
The contribution of the 5hmC modification to gene regulation is actively debated.
Recent studies found that 5hmC gain is accompanied by H3K27me3 loss at promoters
and in the gene body during neurogenesis, suggesting an activating role of 5hmC (Hahn
et al., 2013). On the other hand, the presence of 5hmC at the promoter of bivalently
marked genes (Matarese, 2011; Pastor et al., 2011; Wu et al., 2011) and in
vitro transcription studies revealed a repressive role of 5hmC at promoter regions
(Robertson et al., 2011). However, the role of 5hmC at enhancers has not been
investigated thus far.
We observed that enrichment of 5hmC corresponds with the depletion of eRNAs
at distal TFBSs. Considering that eRNAs correlate with gene transcription (Core et al.,
2008; Wang et al., 2011), we suggest that low levels of 5hmC at enhancers are required
for gene expression. Importantly, we found that a subset of distal TFBSs that carry the
5hmC mark in embryonic stem cells become enriched for the activating histone mark
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(H3K4me1/2) following differentiation into neural progenitors or endomesoderm,
suggesting that distal TFBSs with 5hmC are repressed in mESC but become active
enhancers in a lineage-specific manner. Indeed, using ChIA-PET interaction information
(Zhang et al., 2013), we found that those regions that gained connections to their target
genes were significantly upregulated during differentiation compared with the target
genes in other clusters. This finding suggests that their target genes were repressed in
ESCs and become selectively activated in a lineage-specific way.
To ascertain if the proposed “silent enhancers” identified above can indeed
function as enhancers we employed luciferase reporter assays. We demonstrated that the
novel distal elements, characterized by TF binding, high levels of 5hmC, and absence of
the H3K4me1 “enhancer” mark, can indeed function as enhancers in mESCs if they are
devoid of the 5hmC modification. This experiment is consistent with the notion that
5hmC could inhibit enhancer activity at a subset of distal TFBSs in mESCs.
Our findings are different from the work of Sérandour and colleagues (Serandour
et al., 2012), who had suggested an activating role for 5hmC at distal regulatory regions.
They identified 5hmC peaks after differentiation, which were surrounded by the
activating H3K4me2 mark. However, more than 50% the 5hmC peaks they identified
were located at genic regions, where they are known to be associated with gene activation
(Ficz et al., 2011; Hahn et al., 2013; Huang et al., 2014; Kim et al., 2014; Wu et al.,
2011). It is also possible that the 5hmC peaks at distal regions are associated with noncoding RNAs such as long non-coding RNAs (lincRNAs) (Guttman et al., 2010).
Sérandour and colleagues also identified 5hmC at distal PPARγ binding sites (Nielsen et
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al., 2008). Even though Sérandour and colleagues proposed an activating role of 5hmC at
these master regulator in adipocytes, only a portion of PPARγ binding sites were enriched
for 5hmC (Serandour et al., 2012). We revisited their data and found that 5hmC was only
present at sited lacking PolII occupancy (Figure 3.7), indicating that 5hmC at PPARγ
binding sites bears repressive roles in mature adipocytes.
In hESCs, we also identified a group of distal DHSs with strong 5hmC but weak
H3K4me1 and H3K27ac (Figure 3.6). The GROseq levels were significantly weak for the
group with 5hmC (Figure 3.6). These lines of evidences suggest a general repressive role
of 5hmC at distal regulatory regions.
In ESCs, poised enhancers have been suggested to exist at sites where both
activating marks (H3K4me1) and repressive marks (H3K27me3) are enriched, but
H3K27ac is depleted (Creyghton et al., 2010; Rada-Iglesias et al., 2011). 5fC is enriched
in this type of poised enhancers (H3K4me1[+] and H3K27ac[−]) (Song et al., 2013). In
contrast to these poised enhancers, we identify a novel group of enhancers with no
activating histone marks (H3K4me1[−] and H3K27ac[−]) but enrichment only for 5hmC.
Furthermore, this group is strongly enriched for 5fC, even though cluster 2 lacks the
H3K4me1 mark (Figure 3.2). Our results strongly suggest that 5hmC and 5fC can be
epigenetic mark for poised or silent enhancers. As shown in our results, many of these
enhancers display activating histone marks only after differentiation has occurred (Figure
3.11). The existence of 5hmC and 5fC also show the active oxidation dynamics at these
sites.
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We found that 5hmC was enriched at distal PPARγ binding sites in fully
differentiated adipocytes. These findings suggest 5hmC as a new marker for poised
enhancers even in absence of H3K4me1 and H3K27me3. Additionally, we also found
enriched 5hmC in NPC at the subset of the active TFBSs (except for cluster 2) in mESCs
(Figure 3.15). This may suggest that active enhancers in mESCs are repressed by 5hmC
in NPC to remove the enhancer activities in mESCs.
The majority of cluster 2 regions are CTCF binding sites (Table 3.2). In general,
5hmC levels negatively correlated with CTCF occupancy in cluster 2 (Figure 3.16). After
differentiation into NPCs, 5hmC became depleted at these sites even though the binding
CTCF remained. At these sites, we did not observe activating H3K4me1 and H3K4me2
marks. However, it is difficult to discuss the role of 5hmCs at these sites, because CTCF
takes part in various regulatory roles including transcriptional activation, repression, as
well as the formation of higher order chromatin structure (Nikolaev et al., 2009). The
function of 5hmC in mESCs at CTCF binding sites warrants further study.
We report a new repressive role for 5hmC in gene regulatory regions in mESCs.
The TFBSs enriched for 5hmCs were depleted for nascent transcripts and activating
histone modification marks in human and mouse ESCs. Furthermore, the 5hmC levels
were inversely correlated with PolII occupancy in mESCs as well as in fully
differentiated adipocytes. Our findings indicate that 5hmC has a repressive role at
specific distal regulatory regions and suggest that 5hmC is a new epigenetic mark for
silenced enhancers.
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4.1 TET1-meditated DNA hydroxymethylation is required for the regulation of gene
expression in intestinal stem cells.
	
  

5-hydroxymethycytosine (5hmC) is converted from 5-methylcytosine (5mC) by
Ten-eleven translocation (TET) enzymes, which can further oxidize 5hmC to 5formylcytosine and 5-carboxycytosine (Ito et al., 2011; Kriaucionis and Heintz, 2009;
Tahiliani et al., 2009). These oxidation products are thought to be involved in DNA
demethylation in mammals (Hashimoto et al., 2012; He et al., 2011; Maiti and Drohat,
2011; Valinluck and Sowers, 2007). This suggests that 5hmC could be the first step
towards reversing the repressive effects of 5mC on gene expression (Ficz et al., 2011;
Nestor et al., 2012). Recently, it has been suggested that TET1 and 5hmC are important
for gene expression during differentiation of a human colon carcinoma epithelial cell line
(Chapman et al., 2015).
In Chapter 2, I investigated the role of 5hmC and TET1 during intestinal stem cell
(ISC) maturation and differentiation. To determine the genome-wide map of 5hmC, I
isolated intestinal stem cells and differentiated villus cells from adult mice and performed
hydroxymethylated DNA immunoprecipitation followed by next-generation sequencing. I
found that 5hmC is enriched at highly expressed genes such as the Wnt target genes in
ISCs, and at genes encoding metabolic and transport function in differentiated cells. To
examine if altered DNA hydroxymethylation leads to intestinal defects, I used Tet1-/mice and found growth retardation and postnatal lethality in the mutant mice. In the Tet1deleted postnatal intestine, I observed reduced proliferation, and decreased Wnt target
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gene expression levels, which correlated with significantly decreased 5hmC levels at the
relevant promoter regions in Tet1 null mice. This finding suggests that Tet1-mediated
DNA hydroxymethylation is essential for epigenetic regulation of Wnt target and stem
cell genes in ISCs.
Although I showed that reduced expression of several Wnt target genes correlated
with decreased levels of 5hmC at their promoters in Tet1 null intestinal crypts, in the
future it would be interesting to determine differential 5hmC levels and gene expression
changes in the Tet1 null crypt compared to wild-type crypts on genome-wide in an
unbiased manner using next-generation sequencing. To investigate the details of 5hmC
dynamics during intestinal epithelial differentiation further, single-base resolution
mapping of 5hmC in ISCs and differentiated cells would be helpful. We have already
published single-base resolution map of 5mC in ISCs and differentiated cells (Sheaffer et
al., 2014), and have started preparing DNA libraries for 5hmC mapping at single-base
resolution. With both 5mC and 5hmC maps at single-base resolution, we can identify
DNA methylation and hydroxymethylation levels at each cytosine residue precisely and
characterize their relationship to gene expression with our existing RNA sequencing data
(Sheaffer et al., 2014).
Whereas genome-wide maps for a few transcription factors and histone
modifications in ISCs and differentiated cells are already available (Kim et al., 2012; San
Roman et al., 2015; Sheaffer et al., 2014; Verzi et al., 2013), epigenomic information of
intestinal differentiation and specific cell types is still limited. We have performed
chromatin-immunoprecipation sequencing for several histone modifications, such as
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H3K4me1, H3K4me3 and H3K27me3, and defined open chromatin regions using
transposase-accessible chromatin sequencing (ATAC-seq) in ISCs and differentiated
cells. With all these datasets, integrative analyses will be required for a comprehensive
view of epigenomic regulation during intestinal stem cell differentiation. We have
provided the basis for this integrative analysis, and current and future research is directed
at this problem.
We found postnatal lethality and intestinal defects in Tet1-/- mutant mice, which is
similar to the phenotype seen in mice with conditional deletion of Dnmt1 in the
developing intestine using Dnmt1f/f; VillinCre mice (Elliott et al., 2015; Yu et al., 2015).
This suggests DNA methylation and demethylation are both important for intestinal
maturation in the postnatal period. But, still, the definitive role of Tet1-mediated DNA
hydroxymethylation in the intestine warrants further investigation using intestinalspecific gene ablation models. We have begun to derive Tet1-3f/f mice for conditional
gene deletion in the intestinal epithelium.
To ascertain the critical role of Tet1 in intestinal stem cells, we could examine if
regenerative capacity of Tet1-deleted intestine after radiation injury is altered in future
studies. In the wild-type intestine, intestinal stem cells can repopulate the intestinal
epithelium and show robust regenerative capacity after damage (Booth and Potten, 2000).
We have preliminary results that intestinal regenerative capacity of Tet1-deleted mice is
compromised, which warrants further investigation.
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4.2 5hmC can function as a repressive mark at distal transcription factor binding
sites
	
  

5hmC is not just an intermediate product of the DNA demethylation process. It is
abundant in post-mitotic neuronal cells, and relatively stable showing distinct patterns in
each tissue of the body (Bachman et al., 2014; Kriaucionis and Heintz, 2009; Li and Liu,
2011), and have specific binding proteins (“readers”) that regulate gene expression
(Frauer et al., 2011; Mellén et al., 2012; Spruijt et al., 2013; Yildirim et al., 2011).
Therefore, 5hmC could function as a new stable or semi-stable epigenetic mark, and not
just as a kinetic intermediate towards demethylation. 5hmC is also present at bivalent
promoters of poised developmental genes (Pastor et al., 2011; Wu et al., 2011) and has a
role in pausing or silencing gene expression (Robertson et al., 2011; Szulwach et al.,
2011).
In Chapter 3, we identified putative enhancer sites, which are transcription factor
binding sites (TFBSs) with high levels of 5hmC and no active histone modifications, in
mouse embryonic stem cells (ESCs). We performed integrative analyses with genomewise sequencing datasets of various epigenetic factors, transcription factors, nascent
RNAs and RNA Polymerase II in ESCs, and found about distal 5,000 transcription factor
binding sites as putative enhancer sites fitting these criteria. A subset of them lost 5hmC
and gained active histone marks during ESC differentiation towards a specific lineage.
We also determined the enhancer activity of a subset of these elements when they were
devoid of 5hmC using reporter assays. These findings suggest that 5hmC has a repressive
role at a subset of distal TFBSs, and marks silenced developmental enhancers in ESCs.
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Tet1 and Tet2 are highly expressed in ESCs and are required for ESC
maintenance and proper differentiation. Depletion of Tet1 and Tet2 in ESCs causes
spontaneous and/or skewed differentiation. (Ito et al., 2010; Koh et al., 2011). It is
possible that the silenced developmental enhancers described above could be activated in
these conditions due to decreased levels of 5hmC in Tet1 and Tet2-deficient ESCs, and
that this aberrant enhancer activation contributes to the mutant phenotype.
To further validate the function of silenced developmental enhancers during ESCs
differentiation, we could delete them using clustered regularly interspaced short
palindromic repeats (CRISPR)/CRISPR associated protein system (Cong et al., 2013) in
ESCs and examine the differentiation capacity of mutant ESCs. With this approach, one
could determine whether silenced developmental enhancers are actually necessary to be
activated by loss of 5hmC and the acquisition of active histone modifications.
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4.3 The dual role of 5hmC in gene activation and repression
	
  

Targeting the TET1 catalytic domain to specific CpGs in the promoter proximal
regions for DNA demethylation leads to target gene activation (Maeder et al., 2013). In
chapter 2, high levels of 5hmC in promoters and gene bodies were correlated with active
gene expression in intestinal stem and differentiated cells. This suggests that 5hmC is
involved in DNA demethylation and maintaining an open chromatin structure for active
transcription. However, it has been also shown that 5hmC is enriched at bivalent
promoters of poised developmental genes in embryonic stem cells (Pastor et al., 2011;
Wu et al., 2011). In chapter 3, enrichment of 5hmC suppresses enhancer activity of a
group of distal transcription factor binding sites, which is associated with poised
developmental genes in embryonic stem cells. This suggests that 5hmC is not only
involved in DNA demethylation for gene activation, but can also contribute to gene
repression as a stable epigenetic modification in bivalent promoters and silent enhancers
of poised genes in stem cells.
	
  

	
  

111	
  
	
  

4.4 Reference

Bachman, M., Uribe-Lewis, S., Yang, X., Williams, M., Murrell, A., and
Balasubramanian, S. (2014). 5-Hydroxymethylcytosine is a predominantly stable DNA
modification. Nat Chem 6, 1049-1055.
Booth, C., and Potten, C.S. (2000). Gut instincts: thoughts on intestinal epithelial stem
cells. J Clin Invest 105, 1493-1499.
Chapman, C.G., Mariani, C.J., Wu, F., Meckel, K., Butun, F., Chuang, A., Madzo, J.,
Bissonette, M.B., Kwon, J.H., and Godley, L.A. (2015). TET-catalyzed 5hydroxymethylcytosine regulates gene expression in differentiating colonocytes and
colon cancer. Sci Rep 5, 17568.
Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang,
W., Marraffini, L.A., et al. (2013). Multiplex genome engineering using CRISPR/Cas
systems. Science 339, 819-823.
Elliott, E.N., Sheaffer, K.L., Schug, J., Stappenbeck, T.S., and Kaestner, K.H. (2015).
Dnmt1 is essential to maintain progenitors in the perinatal intestinal epithelium.
Development 142, 2163-2172.
Ficz, G., Branco, M.R., Seisenberger, S., Santos, F., Krueger, F., Hore, T.A., Marques,
C.J., Andrews, S., and Reik, W. (2011). Dynamic regulation of 5-hydroxymethylcytosine
in mouse ES cells and during differentiation. Nature 473, 398-402.
Frauer, C., Hoffmann, T., Bultmann, S., Casa, V., Cardoso, M.C., Antes, I., and
Leonhardt, H. (2011). Recognition of 5-hydroxymethylcytosine by the Uhrf1 SRA
domain. PloS one 6.
Hashimoto, H., Liu, Y., Upadhyay, A.K., Chang, Y., Howerton, S.B., Vertino, P.M.,
Zhang, X., and Cheng, X. (2012). Recognition and potential mechanisms for replication
and erasure of cytosine hydroxymethylation. Nucleic Acids Res 40, 4841-4849.
He, Y.-F.F., Li, B.-Z.Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z.,
Li, L., et al. (2011). Tet-mediated formation of 5-carboxylcytosine and its excision by
TDG in mammalian DNA. Science 333, 1303-1307.
112	
  
	
  

Ito, S., D'Alessio, A.C., Taranova, O.V., Hong, K., Sowers, L.C., and Zhang, Y. (2010).
Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell
mass specification. Nature 466, 1129-1133.
Ito, S., Shen, L., Dai, Q., Wu, S.C., Collins, L.B., Swenberg, J.A., He, C., and Zhang, Y.
(2011). Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5carboxylcytosine. Science 333, 1300-1303.
Kim, T.-H.H., Escudero, S., and Shivdasani, R.A. (2012). Intact function of Lgr5
receptor-expressing intestinal stem cells in the absence of Paneth cells. Proc Natl Acad
Sci USA 109, 3932-3937.
Koh, K.P., Yabuuchi, A., Rao, S., Huang, Y., Cunniff, K., Nardone, J., Laiho, A.,
Tahiliani, M., Sommer, C.A., Mostoslavsky, G., et al. (2011). Tet1 and Tet2 regulate 5hydroxymethylcytosine production and cell lineage specification in mouse embryonic
stem cells. Cell Stem Cell 8, 200-213.
Kriaucionis, S., and Heintz, N. (2009). The nuclear DNA base 5-hydroxymethylcytosine
is present in Purkinje neurons and the brain. Science 324, 929-930.
Li, W., and Liu, M. (2011). Distribution of 5-hydroxymethylcytosine in different human
tissues. J Nucleic Acids 2011, 870726.
Maeder, M.L., Angstman, J.F., Richardson, M.E., Linder, S.J., Cascio, V.M., Tsai, S.Q.,
Ho, Q.H., Sander, J.D., Reyon, D., Bernstein, B.E., et al. (2013). Targeted DNA
demethylation and activation of endogenous genes using programmable TALE-TET1
fusion proteins. Nat Biotechnol 31, 1137-1142.
Maiti, A., and Drohat, A.C. (2011). Thymine DNA glycosylase can rapidly excise 5formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of
CpG sites. J Biol Chem 286, 35334-35338.
Mellén, M., Ayata, P., Dewell, S., Kriaucionis, S., and Heintz, N. (2012). MeCP2 binds
to 5hmC enriched within active genes and accessible chromatin in the nervous system.
Cell 151, 1417-1430.
Nestor, C.E., Ottaviano, R., Reddington, J., Sproul, D., Reinhardt, D., Dunican, D., Katz,
E., Dixon, J.M., Harrison, D.J., and Meehan, R.R. (2012). Tissue type is a major modifier
of the 5-hydroxymethylcytosine content of human genes. Genome Res 22, 467-477.
113	
  
	
  

Pastor, W.A., Pape, U.J., Huang, Y., Henderson, H.R., Lister, R., Ko, M., McLoughlin,
E.M., Brudno, Y., Mahapatra, S., Kapranov, P., et al. (2011). Genome-wide mapping of
5-hydroxymethylcytosine in embryonic stem cells. Nature 473, 394-397.
Robertson, J., Robertson, A.B., and Klungland, A. (2011). The presence of 5hydroxymethylcytosine at the gene promoter and not in the gene body negatively
regulates gene expression. Biochem Biophys Res Commun 411.
San Roman, A.K., Tovaglieri, A., Breault, D.T., and Shivdasani, R.A. (2015). Distinct
Processes and Transcriptional Targets Underlie CDX2 Requirements in Intestinal Stem
Cells and Differentiated Villus Cells. Stem cell Rep 5, 673-681.
Sheaffer, K.L., Kim, R., Aoki, R., Elliott, E.N., Schug, J., Burger, L., Schübeler, D., and
Kaestner, K.H. (2014). DNA methylation is required for the control of stem cell
differentiation in the small intestine. Genes Dev 28, 652-664.
Spruijt, C.G., Gnerlich, F., Smits, A.H., Pfaffeneder, T., Jansen, P.W., Bauer, C., Münzel,
M., Wagner, M., Müller, M., Khan, F., et al. (2013). Dynamic readers for 5(hydroxy)methylcytosine and its oxidized derivatives. Cell 152, 1146-1159.
Szulwach, K.E., Li, X., Li, Y., Song, C.X., Han, J.W., Kim, S., Namburi, S., Hermetz, K.,
Kim, J.J., Rudd, M.K., et al. (2011). Integrating 5-hydroxymethylcytosine into the
epigenomic landscape of human embryonic stem cells. PLoS Genet 7.
Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal,
S., Iyer, L.M., Liu, D.R., Aravind, L., et al. (2009). Conversion of 5-methylcytosine to 5hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930935.
Valinluck, V., and Sowers, L.C. (2007). Endogenous cytosine damage products alter the
site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer research
67, 946-950.
Verzi, M.P., Shin, H., San Roman, A.K., Liu, X.S., and Shivdasani, R.A. (2013).
Intestinal master transcription factor CDX2 controls chromatin access for partner
transcription factor binding. Mol Cell Biol 33, 281-292.
Wu, H., D'Alessio, A.C., Ito, S., Wang, Z., Cui, K., Zhao, K., Sun, Y.E., and Zhang, Y.
(2011). Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual
114	
  
	
  

function in transcriptional regulation in mouse embryonic stem cells. Genes Dev 25, 679684.
Yildirim, O., Li, R., Hung, J.-H.H., Chen, P.B., Dong, X., Ee, L.-S.S., Weng, Z., Rando,
O.J., and Fazzio, T.G. (2011). Mbd3/NURD complex regulates expression of 5hydroxymethylcytosine marked genes in embryonic stem cells. Cell 147, 1498-1510.
Yu, D.-H.H., Gadkari, M., Zhou, Q., Yu, S., Gao, N., Guan, Y., Schady, D., Roshan,
T.N., Chen, M.-H.H., Laritsky, E., et al. (2015). Postnatal epigenetic regulation of
intestinal stem cells requires DNA methylation and is guided by the microbiome.
Genome Biol 16, 211.

115	
  
	
  

